<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
   <atom:link href="http://www.medscape.com/pjsp/public/rss/medscape_expertblog_vid2.xml" rel="self" type="application/rss+xml" />
    <title>Medscape Expert Blogs</title>
    <link>http://www.medscape.com/medscapetoday</link>
    <description>Medscape has recruited high level experts from across Medscape to share their commentary on recent developments in their specialties. 

</description>
	 <itunes:summary>In Medscape&#39;s Expert Blogs, some of the foremost names in medicine share their perspectives on key developments in their specialties.  Experts featured include Drs. Henry Black and Jorge Plutzky on Cardiology, Anne Peters on Diabetes, Eric Topol on Ge</itunes:summary>
	 <itunes:subtitle>The Top Names in Medicine on Medscape </itunes:subtitle>
    <itunes:category text=""></itunes:category>
	<language>en-us</language>
    <copyright>2006. All rights reserved.</copyright>
    <pubDate>Mon, 14 Jul 2008 08:38:00 GMT</pubDate>
    <lastBuildDate>Mon, 14 Jul 2008 08:38:00 GMT</lastBuildDate>
    <generator>Podcastblaster.com</generator>
    <managingEditor>stobrien@webmd.net(Steve O'Brien)</managingEditor>
    <webMaster>stobrien@webmd.net(Steve O'Brien)</webMaster>
    <image>
    <url>http://images.medscape.com/pi/podcast/blogs/itunes_blogs.jpg</url>
    <title>Medscape Expert Blogs</title>
    <link>http://www.medscape.com/medscapetoday</link>
    <width>144</width>
    <height>144</height>
    </image>
    <itunes:owner>
      <itunes:name>Steve</itunes:name>
      <itunes:email>stobrien@webmd.net(Steve O'Brien)</itunes:email>
    </itunes:owner>
    <itunes:author>Medscape</itunes:author>
    <itunes:explicit>no</itunes:explicit>
    <ttl>1</ttl>
    <item>
      <title>Diabetes Prevention and Ralph DeFronzo</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-vblog-Peters04-DiabPrev.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-vblog-Peters04-DiabPrev.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>What did Dr. Anne Peters learn from Dr. Ralph DeFronzo? Find out in this videoblog.</description>
      <pubDate>Mon, 14 Jul 2008 04:51:00 GMT</pubDate>
      <itunes:subtitle>Diabetes Prevention and Ralph DeFronzo</itunes:subtitle>
      <itunes:summary>What did Dr. Anne Peters learn from Dr. Ralph DeFronzo? Find out in this videoblog.</itunes:summary>
      <itunes:keywords>diabetes mellitus type II,adult,depend,dependant,dependent,diabetes,diabetic,dm,insulin,mellitus,niddm,non,non insulin dependent diabetes mellitus,noninsulin,onset,requiring,uncomplicated, </itunes:keywords>
      <itunes:duration>00:03:34</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-vblog-Peters04-DiabPrev.mp4" length="11114906" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-vblog-Peters04-DiabPrev.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>ACCORD, ADVANCE, AVOID: What Do They Tell Us About Treating our Patients?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black10-Accord.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black10-Accord.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>The ACCORD results were negative (for the primary endpoint), the ADVANCE results were positive. Dr. Black compares and contrasts these results with those of the AVOID study.</description>
      <pubDate>Fri, 15 Aug 2008 03:01:00 GMT</pubDate>
      <itunes:subtitle>ACCORD, ADVANCE, AVOID: What Do They Tell Us About Treating our Patients?</itunes:subtitle>
      <itunes:summary>The ACCORD results were negative (for the primary endpoint), the ADVANCE results were positive. Dr. Black compares and contrasts these results with those of the AVOID study.</itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, diabetes mellitus,DM,diabetes,mellitus,sugar, glucose intolerance,impaired glucose tolerance,glucoses,impairment,intolerant, diabetic nephropathy,Kimmelstiel-Wilson syndrome,changes,diabetes,diabet</itunes:keywords>
      <itunes:duration>00:04:51</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black10-Accord.mp4" length="32820429" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black10-Accord.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Should Statins Ever Be Prescribed in Children With Lipid Problems?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black12-Statins.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black12-Statins.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>If children are prescribed statins, they may have to take these drugs for decades. Here, Dr. Black discusses whether clinicians should consider this approach, and what an alternative might be.</description>
      <pubDate>Mon, 18 Aug 2008 03:04:00 GMT</pubDate>
      <itunes:subtitle>Should Statins Ever Be Prescribed in Children With Lipid Problems?</itunes:subtitle>
      <itunes:summary>If children are prescribed statins, they may have to take these drugs for decades. Here, Dr. Black discusses whether clinicians should consider this approach, and what an alternative might be.</itunes:summary>
      <itunes:keywords>atherosclerotic heart disease,arteriosclerotic heart disease,ashd, fat maldistribution lipodystrophy lipoatrophy wasting, </itunes:keywords>
      <itunes:duration>00:02:05</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black12-Statins.mp4" length="14155776" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black12-Statins.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Which Diet is Best? Have the Behaviorists Failed Us?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black11-Diet.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black11-Diet.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his video blog, Dr. Black discusses the recent New England Journal of Medicine comparison of diets -- and makes several important observations about what this means for clinicians, going forward.</description>
      <pubDate>Mon, 18 Aug 2008 03:06:00 GMT</pubDate>
      <itunes:subtitle>Which Diet is Best? Have the Behaviorists Failed Us?</itunes:subtitle>
      <itunes:summary>In his video blog, Dr. Black discusses the recent New England Journal of Medicine comparison of diets -- and makes several important observations about what this means for clinicians, going forward.</itunes:summary>
      <itunes:keywords>obesity,overweight,adiposity,obese,weight, hypertension instructions,blood pressure,bp,diet,hypertensive,recommendations,teaching,watch, lifestyle recommendations,counseling,counselling,diet,discussed,drug,education,encourage,encouraged,exercise,healthy,i</itunes:keywords>
      <itunes:duration>00:03:40</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black11-Diet.mp4" length="24956109" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black11-Diet.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>IVIG and Rituximab Regimen to Reduce Anti-HLA Antibodies In Renal Transplantation</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro01-IVIGandRituximab.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro01-IVIGandRituximab.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>This video blog by Ron Shapiro, MD discusses new clinical trial data on emerging therapeutic options for highly-sensitized renal transplant candidates awaiting transplantation.</description>
      <pubDate>Wed, 06 Aug 2008 03:10:00 GMT</pubDate>
      <itunes:subtitle>IVIG and Rituximab Regimen to Reduce Anti-HLA Antibodies In Renal Transplantation</itunes:subtitle>
      <itunes:summary>This video blog by Ron Shapiro, MD discusses new clinical trial data on emerging therapeutic options for highly-sensitized renal transplant candidates awaiting transplantation.</itunes:summary>
      <itunes:keywords>kidney transplantation,allograft,renal,transplant,transplants, organ transplantation,transplant,transplants, transplantation, immunosuppressive therapy,immunosuppression, </itunes:keywords>
      <itunes:duration>00:02:49</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro01-IVIGandRituximab.mp4" length="18350080" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro01-IVIGandRituximab.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Immunosupression In Kidney Transplantation After Extrarenal Transplantation</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro04-Immunosuppression.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro04-Immunosuppression.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog Ron Shapiro, MD discusses an immunosuppression strategy for renal transplantation in extrarenal transplant recipients with loss of native kidneys to calcineurin inhibitor toxicity.</description>
      <pubDate>Mon, 11 Aug 2008 03:12:00 GMT</pubDate>
      <itunes:subtitle>Immunosupression In Kidney Transplantation After Extrarenal Transplantation</itunes:subtitle>
      <itunes:summary>In this video blog Ron Shapiro, MD discusses an immunosuppression strategy for renal transplantation in extrarenal transplant recipients with loss of native kidneys to calcineurin inhibitor toxicity.</itunes:summary>
      <itunes:keywords>kidney transplantation,allograft,renal,transplant,transplants, organ transplantation,transplant,transplants, transplantation, </itunes:keywords>
      <itunes:duration>00:02:25</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro04-Immunosuppression.mp4" length="15518925" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro04-Immunosuppression.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Renal Allocation and the Perception of Fairness</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro02-RenalAllocation.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro02-RenalAllocation.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog Ron Shapiro, MD discusses the fairness of policies in the United States that shift organ allocation from older to younger recipients.</description>
      <pubDate>Mon, 18 Aug 2008 03:13:00 GMT</pubDate>
      <itunes:subtitle>Renal Allocation and the Perception of Fairness</itunes:subtitle>
      <itunes:summary>In this video blog Ron Shapiro, MD discusses the fairness of policies in the United States that shift organ allocation from older to younger recipients.</itunes:summary>
      <itunes:keywords>kidney transplantation,allograft,renal,transplant,transplants, organ donation, organ transplantation,transplant,transplants, transplantation, </itunes:keywords>
      <itunes:duration>00:02:29</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro02-RenalAllocation.mp4" length="16043213" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro02-RenalAllocation.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>After ENHANCE, Now SEAS: What Do We Know, and How Do We Know It?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black17-SEAStrial.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black17-SEAStrial.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>With more data about Vytorin and ezetimibe being presented at the European cardiology meeting, in this video blog Dr. Black discusses what we should think about the results, given their context.</description>
      <pubDate>Thu, 28 Aug 2008 07:15:00 GMT</pubDate>
      <itunes:subtitle>After ENHANCE, Now SEAS: What Do We Know, and How Do We Know It?</itunes:subtitle>
      <itunes:summary>With more data about Vytorin and ezetimibe being presented at the European cardiology meeting, in this video blog Dr. Black discusses what we should think about the results, given their context.</itunes:summary>
      <itunes:keywords>aortic stenosis,aorta,narrowing,valve, hyperlipidemia,dyslipidemia,abnormalities,abnormality,disease,disorder,dyslipidemic,elevated,hyperlipemia,hyperlipidemias,hyperlipidemic, fat maldistribution lipodystrophy lipoatrophy wasting, </itunes:keywords>
      <itunes:duration>00:02:54</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black17-SEAStrial.mp4" length="20342374" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black17-SEAStrial.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Alemtuzumab Preconditioning with Tacrolimus Monotherapy After Renal Transplantation</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro03-KidneyTransplantation.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro03-KidneyTransplantation.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog Ron Shapiro, MD discusses a novel approach to immunosuppression in renal transplant recipients using preconditioning and spaced immunosuppression. </description>
      <pubDate>Thu, 28 Aug 2008 03:12:00 GMT</pubDate>
      <itunes:subtitle>Alemtuzumab Preconditioning with Tacrolimus Monotherapy After Renal Transplantation</itunes:subtitle>
      <itunes:summary>In this video blog Ron Shapiro, MD discusses a novel approach to immunosuppression in renal transplant recipients using preconditioning and spaced immunosuppression. </itunes:summary>
      <itunes:keywords>immunosuppressive therapy,immunosuppression, </itunes:keywords>
      <itunes:duration>00:02:41</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro03-KidneyTransplantation.mp4" length="17406362" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro03-KidneyTransplantation.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Hand Hygiene: How Can We Improve?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis-HandHygiene-1.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis-HandHygiene-1.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Lisa Maragakis, MD, reviews in her videoblog the serious challenges of measuring and improving hand hygiene compliance in the healthcare setting. </description>
      <pubDate>Tue, 02 Sep 2008 03:15:00 GMT</pubDate>
      <itunes:subtitle>Hand Hygiene: How Can We Improve?</itunes:subtitle>
      <itunes:summary>Lisa Maragakis, MD, reviews in her videoblog the serious challenges of measuring and improving hand hygiene compliance in the healthcare setting. </itunes:summary>
      <itunes:keywords>infection,infected, opportunistic infection,infected,infections, </itunes:keywords>
      <itunes:duration>00:06:16</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis-HandHygiene-1.mp4" length="42047898" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis-HandHygiene-1.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Restricting Nuts, Popcorn, and Corn in Diverticular Disease: A Myth Busted</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson07-DiverticularDisease-1.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson07-DiverticularDisease-1.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his next video blog, Dr. Johnson comments on a recent article in JAMA challenging the evidence supporting the parochial recommendation that individuals with diverticular disease avoid these foods. </description>
      <pubDate>Tue, 02 Sep 2008 03:44:00 GMT</pubDate>
      <itunes:subtitle>Restricting Nuts, Popcorn, and Corn in Diverticular Disease: A Myth Busted</itunes:subtitle>
      <itunes:summary>In his next video blog, Dr. Johnson comments on a recent article in JAMA challenging the evidence supporting the parochial recommendation that individuals with diverticular disease avoid these foods. </itunes:summary>
      <itunes:keywords>diverticular disease,disorder,diverticulitis,diverticulosis, </itunes:keywords>
      <itunes:duration>00:04:30</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson07-DiverticularDisease-1.mp4" length="30618419" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson07-DiverticularDisease-1.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Controversies in Tight Glycemic Control in Critically Ill Adults</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblogShorr06-GlycemicControl.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblogShorr06-GlycemicControl.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>This meta-analysis delves into morbidity and mortality data related to tight glucose control in critically ill patients. </description>
      <pubDate>Mon, 08 Sep 2008 09:06:00 GMT</pubDate>
      <itunes:subtitle>Controversies in Tight Glycemic Control in Critically Ill Adults</itunes:subtitle>
      <itunes:summary>This meta-analysis delves into morbidity and mortality data related to tight glucose control in critically ill patients. </itunes:summary>
      <itunes:keywords>hyperglycemia,bg,blood,blood glucose,elevated,elevated glucose,high,hyperglycemic,increased,sugar, hypoglycemia,blood,hypoglycemic,low,sugar, outcome short-term, critical care,intensive, intensive care unit,care,critical,icu,unit, surgical intensive care </itunes:keywords>
      <itunes:duration>00:04:54</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblogShorr06-GlycemicControl.mp4" length="32086426" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblogShorr06-GlycemicControl.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>The NASCENT Randomized Trial: Ventilator-Associated Pneumonia (VAP)</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblogShorr07-VAP.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblogShorr07-VAP.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Dr Shorr reports on the NASCENT Trial which studied VAP in patients expected to undergo mechanical ventilation who received a silver-coated endotracheal tube. </description>
      <pubDate>Mon, 08 Sep 2008 09:08:00 GMT</pubDate>
      <itunes:subtitle>The NASCENT Randomized Trial: Ventilator-Associated Pneumonia (VAP)</itunes:subtitle>
      <itunes:summary>Dr Shorr reports on the NASCENT Trial which studied VAP in patients expected to undergo mechanical ventilation who received a silver-coated endotracheal tube. </itunes:summary>
      <itunes:keywords>pneumonia,pneumonias, critical care,intensive, intubation endotracheal, intensive care unit,care,critical,icu,unit, ventilation mechanical, medical intensive care unit,icu,micu, surgical intensive care unit,icu,sicu,surgery, ventilator-associated pneumoni</itunes:keywords>
      <itunes:duration>00:04:13</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblogShorr07-VAP.mp4" length="27787264" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblogShorr07-VAP.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Cancer and Healthcare Reform</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HO-vblog-Marshall-HealthCareReform-1_v2.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HO-vblog-Marshall-HealthCareReform-1_v2.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his first video blog for Medscape Oncology, Dr. John Marshall takes a provocative look at the potential impact of healthcare reform on new drug development, on physicians, and on patient care. </description>
      <pubDate>Wed, 10 Sep 2008 03:02:00 GMT</pubDate>
      <itunes:subtitle>Cancer and Healthcare Reform</itunes:subtitle>
      <itunes:summary>In his first video blog for Medscape Oncology, Dr. John Marshall takes a provocative look at the potential impact of healthcare reform on new drug development, on physicians, and on patient care. </itunes:summary>
      <itunes:keywords>drug costs,medication, oncology, health care costs,expenditure,expenditures,health,healthcare, health care economics,healthcare, health care reform,healthcare, insurance health reimbursement, insurance pharmaceutical services,benefit,coverage,drug,medicat</itunes:keywords>
      <itunes:duration>00:06:52</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HO-vblog-Marshall-HealthCareReform-1_v2.mp4" length="45403341" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HO-vblog-Marshall-HealthCareReform-1_v2.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Alemtuzumab and tacrolimus monotherapy after renal transplantation: Results of a Prospective Randomized Trial</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro05-Alemtuzumab.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro05-Alemtuzumab.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog Ron Shapiro, MD discusses new clinical trial data on alemtuzumab and tacrolimus monotherapy after renal transplantation. </description>
      <pubDate>Fri, 12 Sep 2008 03:24:00 GMT</pubDate>
      <itunes:subtitle>Alemtuzumab and tacrolimus monotherapy after renal transplantation: Results of a Prospective Randomized Trial</itunes:subtitle>
      <itunes:summary>In this video blog Ron Shapiro, MD discusses new clinical trial data on alemtuzumab and tacrolimus monotherapy after renal transplantation. </itunes:summary>
      <itunes:keywords>kidney transplantation,allograft,renal,transplant,transplants, organ transplantation,transplant,transplants, immunosuppressive therapy,immunosuppression, </itunes:keywords>
      <itunes:duration>00:02:34</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro05-Alemtuzumab.mp4" length="17091789" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro05-Alemtuzumab.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Autism Spectrum and Psychiatric Comorbidities</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling05-AutismComorbidities.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling05-AutismComorbidities.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>What psychiatric conditions occur most often in patients with autism spectrum disorders? In his latest video blog, Dr. Robert Findling discusses the most common presentations.</description>
      <pubDate>Mon, 15 Sep 2008 04:57:00 GMT</pubDate>
      <itunes:subtitle>Autism Spectrum and Psychiatric Comorbidities</itunes:subtitle>
      <itunes:summary>What psychiatric conditions occur most often in patients with autism spectrum disorders? In his latest video blog, Dr. Robert Findling discusses the most common presentations.</itunes:summary>
      <itunes:keywords>anxiety disorder generalized,diffuse,disease,disorders, autism, </itunes:keywords>
      <itunes:duration>00:03:37</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling05-AutismComorbidities.mp4" length="25375539" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling05-AutismComorbidities.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Community Practitioners Heed Evidence-Based Recommendations</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman13-chemoradiation.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman13-chemoradiation.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his video blog, Dr. Maurie Markman observes that use of chemoradiation in cervical cancer illustrates uptake of strongly evidence-based recommendations by community doctors.</description>
      <pubDate>Wed, 17 Sep 2008 05:01:00 GMT</pubDate>
      <itunes:subtitle>Community Practitioners Heed Evidence-Based Recommendations</itunes:subtitle>
      <itunes:summary>In his video blog, Dr. Maurie Markman observes that use of chemoradiation in cervical cancer illustrates uptake of strongly evidence-based recommendations by community doctors.</itunes:summary>
      <itunes:keywords>chemotherapy, neoplasm malignant cervix,cervical cancer,adenocarcinoma,adenocarcinomas,ca,carcinoma,carcinomas,endocervical,malignancy,malignant neoplasm,neoplasms, radiation oncology, </itunes:keywords>
      <itunes:duration>00:03:04</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman13-chemoradiation.mp4" length="20342374" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman13-chemoradiation.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Have You Ever Used Piperacillin/Tazobactam for Pseudomonas aeruginosa?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Auwaerter07-piperacillintazobactam.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Auwaerter07-piperacillintazobactam.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Paul Auwaerter, MD, reviews the past and present of piperacillin/tazobactam for the treatment of Pseudomonas aeruginosa in this videoblog. </description>
      <pubDate>Thu, 18 Sep 2008 05:03:00 GMT</pubDate>
      <itunes:subtitle>Have You Ever Used Piperacillin/Tazobactam for Pseudomonas aeruginosa?</itunes:subtitle>
      <itunes:summary>Paul Auwaerter, MD, reviews the past and present of piperacillin/tazobactam for the treatment of Pseudomonas aeruginosa in this videoblog. </itunes:summary>
      <itunes:keywords>septicemia,sepsis, antibiotic overuse, antibiotic resistance, antibiotics, </itunes:keywords>
      <itunes:duration>00:04:37</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Auwaerter07-piperacillintazobactam.mp4" length="29360128" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Auwaerter07-piperacillintazobactam.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>The Benefits of Continuous Glucose Monitoring</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-vblog-Peters05-CGMA.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-vblog-Peters05-CGMA.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In her latest videoblog, Dr. Peters discusses the results of a study on continuous glucose monitoring represented at the recent European Association for the Study of Diabetes meeting. </description>
      <pubDate>Fri, 19 Sep 2008 05:04:00 GMT</pubDate>
      <itunes:subtitle>The Benefits of Continuous Glucose Monitoring</itunes:subtitle>
      <itunes:summary>In her latest videoblog, Dr. Peters discusses the results of a study on continuous glucose monitoring represented at the recent European Association for the Study of Diabetes meeting. </itunes:summary>
      <itunes:keywords>hypoglycemia,blood,hypoglycemic,low,sugar, artificial pancreas,</itunes:keywords>
      <itunes:duration>00:03:27</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-vblog-Peters05-CGMA.mp4" length="23383245" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-vblog-Peters05-CGMA.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Is Prehypertension Real, and What Can We Do About It?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black19-PreHT.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black19-PreHT.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his video commentary Dr Black discusses how and why 20-year follow-up results from CARDIA should motivate clinicians to get serious about recognizing &#34;prehypertension&#34; in their younger patients. </description>
      <pubDate>Fri, 19 Sep 2008 05:48:00 GMT</pubDate>
      <itunes:subtitle>Is Prehypertension Real, and What Can We Do About It?</itunes:subtitle>
      <itunes:summary>In his video commentary Dr Black discusses how and why 20-year follow-up results from CARDIA should motivate clinicians to get serious about recognizing &#34;prehypertension&#34; in their younger patients. </itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, </itunes:keywords>
      <itunes:duration>00:05:01</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black19-PreHT.mp4" length="34288435" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black19-PreHT.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Have Genome-wide Association Studies Made Major Contributions?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/GenomicMed-vblog-Topol08-StudyContribution.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/GenomicMed-vblog-Topol08-StudyContribution.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his video blog, Dr. Eric Topol reacts to a story published in Science Times by underscoring the value of genome-wide association studies. </description>
      <pubDate>Fri, 19 Sep 2008 05:51:00 GMT</pubDate>
      <itunes:subtitle>Have Genome-wide Association Studies Made Major Contributions?</itunes:subtitle>
      <itunes:summary>In his video blog, Dr. Eric Topol reacts to a story published in Science Times by underscoring the value of genome-wide association studies. </itunes:summary>
      <itunes:keywords>genomics, pharmacogenomics, </itunes:keywords>
      <itunes:duration>00:02:47</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/GenomicMed-vblog-Topol08-StudyContribution.mp4" length="18140365" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/GenomicMed-vblog-Topol08-StudyContribution.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Update: Injectible Contraception and Skeletal Health Concerns</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz01-DMPA_v2.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz01-DMPA_v2.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Andrew Kaunitz's GYN Video Blog: Injectible Contraception and Skeletal Health. What\'s the latest on DMPA and bone concerns?</description>
      <pubDate>Mon, 22 Sep 2008 05:53:00 GMT</pubDate>
      <itunes:subtitle>Update: Injectible Contraception and Skeletal Health Concerns</itunes:subtitle>
      <itunes:summary>Andrew Kaunitz's GYN Video Blog: Injectible Contraception and Skeletal Health. What\'s the latest on DMPA and bone concerns?</itunes:summary>
      <itunes:keywords>contraceptive management,family planning,birth,contraception,contraceptives,control,counseling,counselling, women\'s health, </itunes:keywords>
      <itunes:duration>00:02:49</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz01-DMPA_v2.mp4" length="17720934" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz01-DMPA_v2.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Performance of Procedures at US Nephrology Training Programs</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns01-RenalFellowshipTraining_v2.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns01-RenalFellowshipTraining_v2.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Jeffrey Berns, MD, from the University of Pennsylvania, analyzes the performance of procedures performed by nephrologists and nephrology fellows at US nephrology training programs in this video blog. </description>
      <pubDate>Mon, 22 Sep 2008 05:54:00 GMT</pubDate>
      <itunes:subtitle>Performance of Procedures at US Nephrology Training Programs</itunes:subtitle>
      <itunes:summary>Jeffrey Berns, MD, from the University of Pennsylvania, analyzes the performance of procedures performed by nephrologists and nephrology fellows at US nephrology training programs in this video blog. </itunes:summary>
      <itunes:keywords>renal disease,kidney disease,nephrosis,difficultly,disorder,disorders,dysfunction,nephropathy, fellowship,fellow,fellows, medical students, </itunes:keywords>
      <itunes:duration>00:05:38</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns01-RenalFellowshipTraining_v2.mp4" length="37539021" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns01-RenalFellowshipTraining_v2.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>An Update on the PRoFESS Trial</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-vblog-Alberts03-PRoFESSTrial.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-vblog-Alberts03-PRoFESSTrial.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his latest videoblog, Dr. Alberts provides an update on the landmark PRoFESS trial. </description>
      <pubDate>Tue, 23 Sep 2008 05:56:00 GMT</pubDate>
      <itunes:subtitle>An Update on the PRoFESS Trial</itunes:subtitle>
      <itunes:summary>In his latest videoblog, Dr. Alberts provides an update on the landmark PRoFESS trial. </itunes:summary>
      <itunes:keywords>cerebrovascular accident,CVA,accident,acute,apoplexy,cerebral,stroke,vascular, </itunes:keywords>
      <itunes:duration>00:03:32</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-vblog-Alberts03-PRoFESSTrial.mp4" length="22754099" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-vblog-Alberts03-PRoFESSTrial.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Colorectal Cancer: KRAS Changes Everything</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall02-KRAS-1.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall02-KRAS-1.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. John Marshall explains how recent findings about the KRAS gene have profound implications both for our approach to colorectal cancer as a disease, as well as for treatment. </description>
      <pubDate>Thu, 25 Sep 2008 06:20:00 GMT</pubDate>
      <itunes:subtitle>Colorectal Cancer: KRAS Changes Everything</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. John Marshall explains how recent findings about the KRAS gene have profound implications both for our approach to colorectal cancer as a disease, as well as for treatment. </itunes:summary>
      <itunes:keywords></itunes:keywords>
      <itunes:duration>00:06:10</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall02-KRAS-1.mp4" length="38482739" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall02-KRAS-1.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>CT Colonography for CRC Screening: Virtually Ready for Prime Time?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson08-CTColography.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson08-CTColography.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his next video blog for Medscape Gastroenterology, Dr. Johnson provides an overview of the long-awaited CT colonography CRC screening trial comparing CTC and optical colonoscopy. </description>
      <pubDate>Fri, 26 Sep 2008 03:08:00 GMT</pubDate>
      <itunes:subtitle>CT Colonography for CRC Screening: Virtually Ready for Prime Time?</itunes:subtitle>
      <itunes:summary>In his next video blog for Medscape Gastroenterology, Dr. Johnson provides an overview of the long-awaited CT colonography CRC screening trial comparing CTC and optical colonoscopy. </itunes:summary>
      <itunes:keywords>colonoscopy, disease screening,disorder,preventative,preventive,screenings, </itunes:keywords>
      <itunes:duration>00:04:51</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson08-CTColography.mp4" length="31771853" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson08-CTColography.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Unrelated Kidney Transplantation: Commerce and Kidney Vending In Pakistan</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro06-KidneyVendors.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro06-KidneyVendors.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog Ron Shapiro, MD discusses kidney vending of unrelated kidney transplants in Pakistan. </description>
      <pubDate>Fri, 26 Sep 2008 04:03:00 GMT</pubDate>
      <itunes:subtitle>Unrelated Kidney Transplantation: Commerce and Kidney Vending In Pakistan</itunes:subtitle>
      <itunes:summary>In this video blog Ron Shapiro, MD discusses kidney vending of unrelated kidney transplants in Pakistan. </itunes:summary>
      <itunes:keywords>kidney transplantation,allograft,renal,transplant,transplants, transplantation, </itunes:keywords>
      <itunes:duration>00:02:27</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro06-KidneyVendors.mp4" length="15414067" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro06-KidneyVendors.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Use of Combination ACE Inhibitors and ARB Therapy in Patients With Chronic Kidney Disease</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns02-ARBACEI.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns02-ARBACEI.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Jeffrey S. Berns, MD, from the Hospital of the University of Pennsylvania, discusses the use of combination ACE inhibitors and ARB therapy in patients with chronic kidney disease in this video blog. </description>
      <pubDate>Mon, 29 Sep 2008 04:08:00 GMT</pubDate>
      <itunes:subtitle>Use of Combination ACE Inhibitors and ARB Therapy in Patients With Chronic Kidney Disease</itunes:subtitle>
      <itunes:summary>Jeffrey S. Berns, MD, from the Hospital of the University of Pennsylvania, discusses the use of combination ACE inhibitors and ARB therapy in patients with chronic kidney disease in this video blog. </itunes:summary>
      <itunes:keywords>chronic renal failure,renal failure chronic,renal insufficiency chronic,crf,kidney, cardiovascular disease,dis,disorder,disorders, renal disease,kidney disease,nephrosis,difficultly,disorder,disorders,dysfunction,nephropathy, </itunes:keywords>
      <itunes:duration>00:04:19</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns02-ARBACEI.mp4" length="27996979" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns02-ARBACEI.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>The FDA Has Now Spoken: Has the Time for First-line Fixed-dose Combination Therapy Arrived?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black18-DualTherapy.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black18-DualTherapy.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>VALUE and ASCOT showed important benefits for treating hypertension early and intensively -- in his video commentary Dr Black considers whether the FDA has drawn the appropriate conclusions. </description>
      <pubDate>Mon, 29 Sep 2008 04:10:00 GMT</pubDate>
      <itunes:subtitle>The FDA Has Now Spoken: Has the Time for First-line Fixed-dose Combination Therapy Arrived?</itunes:subtitle>
      <itunes:summary>VALUE and ASCOT showed important benefits for treating hypertension early and intensively -- in his video commentary Dr Black considers whether the FDA has drawn the appropriate conclusions. </itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, increased blood pressure,elevated blood pressure,bp, </itunes:keywords>
      <itunes:duration>00:03:34</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black18-DualTherapy.mp4" length="24536678" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black18-DualTherapy.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Extensive Testing Finds More Cancer in Patients With Unprovoked Deep Vein Thrombosis</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HO-vblog-Markman14-DeepVeinThrombosis.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HO-vblog-Markman14-DeepVeinThrombosis.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Significantly more undiagnosed cancers are detected when patients who present with unprovoked deep vein thrombosis undergo extensive tests at baseline, points out Dr. Maurie Markman in this video blog. </description>
      <pubDate>Mon, 29 Sep 2008 04:13:00 GMT</pubDate>
      <itunes:subtitle>Extensive Testing Finds More Cancer in Patients With Unprovoked Deep Vein Thrombosis</itunes:subtitle>
      <itunes:summary>Significantly more undiagnosed cancers are detected when patients who present with unprovoked deep vein thrombosis undergo extensive tests at baseline, points out Dr. Maurie Markman in this video blog. </itunes:summary>
      <itunes:keywords>deep venous thrombophlebitis,DVT,deep vein thrombosis,phlebitis,thromboembolic,thromboembolism,thromboembolus,thrombosis, neoplasm malignant,adenocarcinoma,adenocarcinomas,cancer,neoplasia,neoplasias,neoplasms, </itunes:keywords>
      <itunes:duration>00:02:46</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HO-vblog-Markman14-DeepVeinThrombosis.mp4" length="18454938" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HO-vblog-Markman14-DeepVeinThrombosis.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Assessing Osteoporotic Fracture Risk in Menopausal Patients: Who Should We Treat?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz02-OsteoporoticFractures.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz02-OsteoporoticFractures.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Andrew Kaunitz's Gyn Video Blog: Should long-term antifracture therapy be initiated in the low-risk woman described in this case? </description>
      <pubDate>Thu, 02 Oct 2008 04:16:00 GMT</pubDate>
      <itunes:subtitle>Assessing Osteoporotic Fracture Risk in Menopausal Patients: Who Should We Treat?</itunes:subtitle>
      <itunes:summary>Andrew Kaunitz's Gyn Video Blog: Should long-term antifracture therapy be initiated in the low-risk woman described in this case? </itunes:summary>
      <itunes:keywords>osteoporosis,osteoporotic, osteoporosis risk,osteoporotic,unspecified, menopausal syndrome,climacteric state female,menopause,status,symptom,symptoms,syndromes,woman,women, women\'s health, fracture bone,bones,broken,fractured,fractures,fx, postmenopausal</itunes:keywords>
      <itunes:duration>00:03:09</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz02-OsteoporoticFractures.mp4" length="20132659" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz02-OsteoporoticFractures.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Coffee -- The Good, the Bad, and the We Don't Know Yet</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black20-Coffee.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black20-Coffee.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his video commentary Dr Black discusses the long-term results with coffee from the Health Professionals Study and the Nurses Health Study -- good news, but why? The caffeine? The antioxidants? </description>
      <pubDate>Thu, 02 Oct 2008 04:18:00 GMT</pubDate>
      <itunes:subtitle>Coffee -- The Good, the Bad, and the We Don't Know Yet</itunes:subtitle>
      <itunes:summary>In his video commentary Dr Black discusses the long-term results with coffee from the Health Professionals Study and the Nurses Health Study -- good news, but why? The caffeine? The antioxidants? </itunes:summary>
      <itunes:keywords>neoplasm malignant,adenocarcinoma,adenocarcinomas,cancer,neoplasia,neoplasias,neoplasms, risk management, </itunes:keywords>
      <itunes:duration>00:03:10</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black20-Coffee.mp4" length="21600666" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black20-Coffee.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Playing the Healthcare Market--No Longer a Game</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-PlayingHealthcareMarket.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-PlayingHealthcareMarket.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Will commercial health care survive the debacle of the investment houses? </description>
      <pubDate>Thu, 02 Oct 2008 04:21:00 GMT</pubDate>
      <itunes:subtitle>Playing the Healthcare Market--No Longer a Game</itunes:subtitle>
      <itunes:summary>Will commercial health care survive the debacle of the investment houses? </itunes:summary>
      <itunes:keywords>family practice,medicine, health care costs,expenditure,expenditures,health,healthcare, health care reform,healthcare, HMO,health,hmos,maintenance,organization, national health insurance United States, private practice, health services, practice expenses,</itunes:keywords>
      <itunes:duration>00:03:18</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-PlayingHealthcareMarket.mp4" length="21286093" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-PlayingHealthcareMarket.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Let's Not Give Up on Dual Antibodies in Colon Cancer...Yet</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall03-DualAntibodyColon.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall03-DualAntibodyColon.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. John Marshall observes that despite unexpected negative results in the PACCE and CAIRO2 trials, dual antibody therapy may yet play a role in colorectal cancer. </description>
      <pubDate>Sat, 04 Oct 2008 08:17:00 GMT</pubDate>
      <itunes:subtitle>Let's Not Give Up on Dual Antibodies in Colon Cancer...Yet</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. John Marshall observes that despite unexpected negative results in the PACCE and CAIRO2 trials, dual antibody therapy may yet play a role in colorectal cancer. </itunes:summary>
      <itunes:keywords>Monoclonal Antibodies,antibody, chemotherapy, neoplasm malignant colon,adenocarcinoma,adenocarcinomas,ca,cancer,carcinoma,carcinomas,intestine,large,malignancy,malignant neoplasm,neoplasms, </itunes:keywords>
      <itunes:duration>00:05:23</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall03-DualAntibodyColon.mp4" length="36805018" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall03-DualAntibodyColon.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Collective Bargaining--Go to Jail</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-CollectiveBargaining.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-CollectiveBargaining.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Robert Morrow, MD points out that it's illegal for physicians to negotiate for pay increase. Now What? </description>
      <pubDate>Thu, 09 Oct 2008 08:28:00 GMT</pubDate>
      <itunes:subtitle>Collective Bargaining--Go to Jail</itunes:subtitle>
      <itunes:summary>Robert Morrow, MD points out that it's illegal for physicians to negotiate for pay increase. Now What? </itunes:summary>
      <itunes:keywords>family practice,medicine, practice management, health care reform,healthcare, practice management medical, private practice, professional practice, practice expenses,expense, practice expenses Medicare,expense, </itunes:keywords>
      <itunes:duration>00:03:43</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-CollectiveBargaining.mp4" length="23488102" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-CollectiveBargaining.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>The Results of the Long-Awaited UK Prospective Diabetes Study (UKPDS)</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-vblog-Peters06-UKPDS.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-vblog-Peters06-UKPDS.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In her latest video blog, Dr. Peters discusses the long-term follow-up results from the UK Prospective Diabetes Study. </description>
      <pubDate>Mon, 13 Oct 2008 08:31:00 GMT</pubDate>
      <itunes:subtitle>The Results of the Long-Awaited UK Prospective Diabetes Study (UKPDS)</itunes:subtitle>
      <itunes:summary>In her latest video blog, Dr. Peters discusses the long-term follow-up results from the UK Prospective Diabetes Study. </itunes:summary>
      <itunes:keywords>diabetes mellitus,DM,diabetes,mellitus,sugar, diabetes mellitus type II,adult,depend,dependant,dependent,diabetes,diabetic,dm,insulin,mellitus,niddm,non,non insulin dependent diabetes mellitus,noninsulin,onset,requiring,uncomplicated, hyperglycemia,bg,blo</itunes:keywords>
      <itunes:duration>00:03:26</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-vblog-Peters06-UKPDS.mp4" length="23173530" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-vblog-Peters06-UKPDS.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>What's New in Medical Therapy for Ureteral Stones</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/URO-vblog-Carson02-RenalStones.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/URO-vblog-Carson02-RenalStones.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Dr. Culley Carson gives some highlights from recent studies on expulsive therapy for ureteral stones, including alpha blockers, calcium channel blockers, COX inhibitors, and steroids. </description>
      <pubDate>Mon, 13 Oct 2008 08:32:00 GMT</pubDate>
      <itunes:subtitle>What's New in Medical Therapy for Ureteral Stones</itunes:subtitle>
      <itunes:summary>Dr. Culley Carson gives some highlights from recent studies on expulsive therapy for ureteral stones, including alpha blockers, calcium channel blockers, COX inhibitors, and steroids. </itunes:summary>
      <itunes:keywords>renal calculus,calculi,kidney,lithiasis,nephrolithiasis,stone,stones, ureteral calculus,ureterolithiasis,stone,ureter, </itunes:keywords>
      <itunes:duration>00:04:04</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/URO-vblog-Carson02-RenalStones.mp4" length="27262976" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/URO-vblog-Carson02-RenalStones.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Another Good Reason Not to Smoke</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman15-HPVsmoking.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman15-HPVsmoking.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. Maurie Markman reports on a study suggesting that smoking may potentiate the carcinogenic effect of high-risk HPV infection in women. </description>
      <pubDate>Mon, 13 Oct 2008 08:36:00 GMT</pubDate>
      <itunes:subtitle>Another Good Reason Not to Smoke</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. Maurie Markman reports on a study suggesting that smoking may potentiate the carcinogenic effect of high-risk HPV infection in women. </itunes:summary>
      <itunes:keywords>smoker,active,cigarets,cigarette,cigarettes,current,smoking, neoplasm malignant cervix,cervical cancer,adenocarcinoma,adenocarcinomas,ca,carcinoma,carcinomas,endocervical,malignancy,malignant neoplasm,neoplasms, women's health, human papillomavirus,hpv</itunes:keywords>
      <itunes:duration>00:02:43</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman15-HPVsmoking.mp4" length="17720934" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman15-HPVsmoking.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>The European Cooperative Acute Stroke Study (ECASS 3): Results of a Randomized Trial</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-vblog-Alberts04-Stroke.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-vblog-Alberts04-Stroke.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his latest video blog, Dr. Alberts discusses the results from The European Cooperative Acute Stroke Study (ECASS 3). </description>
      <pubDate>Tue, 14 Oct 2008 08:39:00 GMT</pubDate>
      <itunes:subtitle>The European Cooperative Acute Stroke Study (ECASS 3): Results of a Randomized Trial</itunes:subtitle>
      <itunes:summary>In his latest video blog, Dr. Alberts discusses the results from The European Cooperative Acute Stroke Study (ECASS 3). </itunes:summary>
      <itunes:keywords>intracerebral hemorrhage,hemorrhage intracerebral,hemorrhages,hemorrhagic, thrombolytic therapy, </itunes:keywords>
      <itunes:duration>00:04:08</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-vblog-Alberts04-Stroke.mp4" length="25585254" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-vblog-Alberts04-Stroke.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>How Bad Is Hyperphosphatemia? Are Phosphate Binders Any Better?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns03-PhosphateBinders.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns03-PhosphateBinders.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Jeffrey S. Berns, MD, from the Hospital of the University of Pennsylvania, reviews literature and discusses issues regarding the use of phosphate binders in dialysis patients in this video blog. </description>
      <pubDate>Tue, 14 Oct 2008 08:41:00 GMT</pubDate>
      <itunes:subtitle>How Bad Is Hyperphosphatemia? Are Phosphate Binders Any Better?</itunes:subtitle>
      <itunes:summary>Jeffrey S. Berns, MD, from the Hospital of the University of Pennsylvania, reviews literature and discusses issues regarding the use of phosphate binders in dialysis patients in this video blog. </itunes:summary>
      <itunes:keywords>chronic renal failure,renal failure chronic,renal insufficiency chronic,crf,kidney, hemodialysis,dialysis,kidney,renal, renal disease,kidney disease,nephrosis,difficultly,disorder,disorders,dysfunction,nephropathy, guidelines, treatment guidelines,tx, lit</itunes:keywords>
      <itunes:duration>00:03:35</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns03-PhosphateBinders.mp4" length="23907533" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns03-PhosphateBinders.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Diagnostic Challenges in Adolescent Schizophrenia</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling06-AdolescentSchiz.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling06-AdolescentSchiz.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Both overdiagnosis and misdiagnosis plague early onset schizophrenia. Dr. Robert Findling outlines the challenges in his latest video blog. </description>
      <pubDate>Wed, 15 Oct 2008 04:33:00 GMT</pubDate>
      <itunes:subtitle>Diagnostic Challenges in Adolescent Schizophrenia</itunes:subtitle>
      <itunes:summary>Both overdiagnosis and misdiagnosis plague early onset schizophrenia. Dr. Robert Findling outlines the challenges in his latest video blog. </itunes:summary>
      <itunes:keywords>schizophrenia,schizophrenic, pediatrics, </itunes:keywords>
      <itunes:duration>00:05:25</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling06-AdolescentSchiz.mp4" length="36490445" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling06-AdolescentSchiz.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Stephen Paget's Highlight for ACR 2008 - Part 1 </title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Rheum-vblog-Paget04-ACR2008Part1.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Rheum-vblog-Paget04-ACR2008Part1.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Stephen Paget, MD, on some of the studies and new developments at the 2008 ACR meeting. Genetic profiling, atherosclerosis in lupus and RA and SLE treatment are some of the studies highlighted. </description>
      <pubDate>Wed, 15 Oct 2008 04:36:00 GMT</pubDate>
      <itunes:subtitle>Stephen Paget's Highlight for ACR 2008 - Part 1 </itunes:subtitle>
      <itunes:summary>Stephen Paget, MD, on some of the studies and new developments at the 2008 ACR meeting. Genetic profiling, atherosclerosis in lupus and RA and SLE treatment are some of the studies highlighted. </itunes:summary>
      <itunes:keywords>lupus, arthritis,arthritic,arthritides,inflammation,inflammations,joint, arthritis rheumatoid,arthritic,arthritides,ra,rheumatoid arthritis, osteoarthritis,degenerative joint disease,arthritic,arthritides,arthritis,chronic,degenerativa,degenerative,diseas</itunes:keywords>
      <itunes:duration>00:05:06</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Rheum-vblog-Paget04-ACR2008Part1.mp4" length="28940698" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Rheum-vblog-Paget04-ACR2008Part1.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Long-Acting Reversible Contraception: The Best Kept Birth Control Secret?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz03-longactingcontarcepton.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz03-longactingcontarcepton.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>There are more non-daily birth control options than ever before. Here's a quick overview of the latest methods. </description>
      <pubDate>Wed, 15 Oct 2008 04:39:00 GMT</pubDate>
      <itunes:subtitle>Long-Acting Reversible Contraception: The Best Kept Birth Control Secret?</itunes:subtitle>
      <itunes:summary>There are more non-daily birth control options than ever before. Here's a quick overview of the latest methods. </itunes:summary>
      <itunes:keywords>contraceptive management,family planning,birth,contraception,contraceptives,control,counseling,counselling, </itunes:keywords>
      <itunes:duration>00:04:48</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz03-longactingcontarcepton.mp4" length="30932992" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz03-longactingcontarcepton.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Denominators R Us</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-DenominatorsRUs.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-DenominatorsRUs.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>How do Plans decide on our bonuses? What's the math? </description>
      <pubDate>Thu, 16 Oct 2008 04:41:00 GMT</pubDate>
      <itunes:subtitle>Denominators R Us</itunes:subtitle>
      <itunes:summary>How do Plans decide on our bonuses? What's the math? </itunes:summary>
      <itunes:keywords>health care costs,expenditure,expenditures,health,healthcare, health care reform,healthcare, HMO,health,hmos,maintenance,organization, insurance health, health care facilities manpower and services,healthcare, </itunes:keywords>
      <itunes:duration>00:03:53</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-DenominatorsRUs.mp4" length="25480397" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-DenominatorsRUs.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>A Call to Arms (and Noses): Influenza Vaccination of Healthcare Workers</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis02-FluVacHealthcareWorkers_pt1.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis02-FluVacHealthcareWorkers_pt1.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Do data suggest that vaccination of healthcare workers prevents infection in their patients? Lisa Maragakis, MD, MPH, discusses recent evidence in her video blog. </description>
      <pubDate>Thu, 16 Oct 2008 04:43:00 GMT</pubDate>
      <itunes:subtitle>A Call to Arms (and Noses): Influenza Vaccination of Healthcare Workers</itunes:subtitle>
      <itunes:summary>Do data suggest that vaccination of healthcare workers prevents infection in their patients? Lisa Maragakis, MD, MPH, discusses recent evidence in her video blog. </itunes:summary>
      <itunes:keywords>influenza,grippe,flu, immunization,vaccination,immunizations,shots,vaccinations, vaccine preventative,preventive, guidelines, </itunes:keywords>
      <itunes:duration>00:04:08</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis02-FluVacHealthcareWorkers_pt1.mp4" length="25270682" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis02-FluVacHealthcareWorkers_pt1.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>KDOQI 2008 and Beyond: Revising Current Guidelines</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns04-KDOQI.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns04-KDOQI.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Jeffrey S. Berns, MD, from the Hospital of the University of Pennsylvania, discusses the relaunch of the KDOQI process and what it means for clinical practice in this video blog. </description>
      <pubDate>Fri, 17 Oct 2008 04:46:00 GMT</pubDate>
      <itunes:subtitle>KDOQI 2008 and Beyond: Revising Current Guidelines</itunes:subtitle>
      <itunes:summary>Jeffrey S. Berns, MD, from the Hospital of the University of Pennsylvania, discusses the relaunch of the KDOQI process and what it means for clinical practice in this video blog. </itunes:summary>
      <itunes:keywords>chronic renal failure,renal failure chronic,renal insufficiency chronic,crf,kidney, renal failure end stage,ESRD,renal disease end stage,anemia,chronic,disorder,end stage renal disease,kidney,low blood count, renal disease,kidney disease,nephrosis,difficu</itunes:keywords>
      <itunes:duration>00:03:16</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns04-KDOQI.mp4" length="22020096" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns04-KDOQI.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Treatment of Antibody-Mediated Rejection Improves Renal function In Kidney Transplant Recipients Without Significant Changes in Donor-Specific Antibody</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro07-DSA.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro07-DSA.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog Ron Shapiro, MD discusses the level of DSA that allows for successful kidney transplantation after desensitization with IVIG. </description>
      <pubDate>Mon, 20 Oct 2008 01:44:00 GMT</pubDate>
      <itunes:subtitle>Treatment of Antibody-Mediated Rejection Improves Renal function In Kidney Transplant Recipients Without Significant Changes in Donor-Specific Antibody</itunes:subtitle>
      <itunes:summary>In this video blog Ron Shapiro, MD discusses the level of DSA that allows for successful kidney transplantation after desensitization with IVIG. </itunes:summary>
      <itunes:keywords>kidney transplantation,allograft,renal,transplant,transplants, </itunes:keywords>
      <itunes:duration>00:01:37</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro07-DSA.mp4" length="10380902" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro07-DSA.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Pancreatic Cancer: More Than One Flavor?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall04-PancreasCancer.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall04-PancreasCancer.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this videoblog, Dr. John Marshall talks about how our growing ability to prospectively define tumors according to their genetics is likely to be the key to applying highly effective anticancer treatments.</description>
      <pubDate>Mon, 20 Oct 2008 01:47:00 GMT</pubDate>
      <itunes:subtitle>Pancreatic Cancer: More Than One Flavor?</itunes:subtitle>
      <itunes:summary>In this videoblog, Dr. John Marshall talks about how our growing ability to prospectively define tumors according to their genetics is likely to be the key to applying highly effective anticancer treatments.</itunes:summary>
      <itunes:keywords>neoplasm malignant pancreas,adenocarcinoma,adenocarcinomas,ca,cancer,carcinoma,carcinomas,neoplasms,pancreatic, chemotherapy, </itunes:keywords>
      <itunes:duration>00:03:12</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall04-PancreasCancer.mp4" length="21390950" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall04-PancreasCancer.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Stephen Paget's Highlight for ACR 2008: Part 2</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Rheum-vblog-Paget04-ACR2008Part2.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Rheum-vblog-Paget04-ACR2008Part2.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Stephen Paget, MD, on some of the studies and new developments at the 2008 ACR meeting. Role of vitamin D in inflammatory diseases, gout, and spondyloarthropathies are some of the studies highlighted.</description>
      <pubDate>Wed, 22 Oct 2008 01:49:00 GMT</pubDate>
      <itunes:subtitle>Stephen Paget's Highlight for ACR 2008: Part 2</itunes:subtitle>
      <itunes:summary>Stephen Paget, MD, on some of the studies and new developments at the 2008 ACR meeting. Role of vitamin D in inflammatory diseases, gout, and spondyloarthropathies are some of the studies highlighted.</itunes:summary>
      <itunes:keywords>arthritis,arthritic,arthritides,inflammation,inflammations,joint, gout,gouty, Monoclonal Antibodies,antibody, infection,infected, conferences medical, inflammation,inflammations, </itunes:keywords>
      <itunes:duration>00:04:25</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Rheum-vblog-Paget04-ACR2008Part2.mp4" length="27682406" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Rheum-vblog-Paget04-ACR2008Part2.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Healthcare Worker Influenza Vaccination: Motivation or Mandates?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis02-FluVacHealthcareWorkers_pt2_v2.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis02-FluVacHealthcareWorkers_pt2_v2.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>How can we improve influenza vaccination compliance rates among healthcare workers? Lisa Maragakis, MD, MPH, discusses multiple strategies that have succeeded.</description>
      <pubDate>Wed, 22 Oct 2008 01:51:00 GMT</pubDate>
      <itunes:subtitle>Healthcare Worker Influenza Vaccination: Motivation or Mandates?</itunes:subtitle>
      <itunes:summary>How can we improve influenza vaccination compliance rates among healthcare workers? Lisa Maragakis, MD, MPH, discusses multiple strategies that have succeeded.</itunes:summary>
      <itunes:keywords>influenza,grippe,flu, immunization,vaccination,immunizations,shots,vaccinations, </itunes:keywords>
      <itunes:duration>00:03:58</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis02-FluVacHealthcareWorkers_pt2_v2.mp4" length="26843546" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis02-FluVacHealthcareWorkers_pt2_v2.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Ruc-Ruc-Ruc</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-RucRucRuc.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-RucRucRuc.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>The Stooges at the AMA have stuck primary care in the eye--again </description>
      <pubDate>Thu, 23 Oct 2008 01:55:00 GMT</pubDate>
      <itunes:subtitle>Ruc-Ruc-Ruc</itunes:subtitle>
      <itunes:summary>The Stooges at the AMA have stuck primary care in the eye--again </itunes:summary>
      <itunes:keywords>health care costs,expenditure,expenditures,health,healthcare, health care reform,healthcare, insurance health, insurance health reimbursement, health services, health care delivery,healthcare, health plans, health care services,healthcare, </itunes:keywords>
      <itunes:duration>00:03:06</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-RucRucRuc.mp4" length="19713229" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-RucRucRuc.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Recent Studies on the Use of Inhaled Anticholinergics in Patients With COPD</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblog-Shorr08-PulmonaryUpdate.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblog-Shorr08-PulmonaryUpdate.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Dr. Andrew Shorr discusses recent studies from JAMA and NEJM that focus on inhaled anticholinergics used in the treatment of COPD. </description>
      <pubDate>Thu, 30 Oct 2008 01:57:00 GMT</pubDate>
      <itunes:subtitle>Recent Studies on the Use of Inhaled Anticholinergics in Patients With COPD</itunes:subtitle>
      <itunes:summary>Dr. Andrew Shorr discusses recent studies from JAMA and NEJM that focus on inhaled anticholinergics used in the treatment of COPD. </itunes:summary>
      <itunes:keywords>chronic obstructive pulmonary disease,COPD,airway,cao,chronic,disease,disorder,lung,obstruction,obstructions,obstructive,pulmonary, chronic obstructive pulmonary disease mild,COPD mild,airway,airways,chronic,disease,disorder,minimal,obstruction,obstructio</itunes:keywords>
      <itunes:duration>00:05:42</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblog-Shorr08-PulmonaryUpdate.mp4" length="37958451" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblog-Shorr08-PulmonaryUpdate.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>NYC's Programs on CVD Prevention: A Conversation With NYC's Director for CVD Prevention and Control</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black21-NYCPrograms.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black21-NYCPrograms.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video commentary, Dr. Black discusses New York City's approach to CVD prevention and control with Sonia Angell, MD, the Director of the City's program.</description>
      <pubDate>Fri, 24 Oct 2008 05:49:00 GMT</pubDate>
      <itunes:subtitle>NYC's Programs on CVD Prevention: A Conversation With NYC's Director for CVD Prevention and Control</itunes:subtitle>
      <itunes:summary>In this video commentary, Dr. Black discusses New York City's approach to CVD prevention and control with Sonia Angell, MD, the Director of the City's program.</itunes:summary>
      <itunes:keywords>smoker,active,cigarets,cigarette,cigarettes,current,smoking, cardiovascular disease,dis,disorder,disorders, hypertension instructions,blood pressure,bp,diet,hypertensive,recommendations,teaching,watch, preventive care,preventative care,medicine,prevention</itunes:keywords>
      <itunes:duration>00:03:46</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black21-NYCPrograms.mp4" length="25480397" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black21-NYCPrograms.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>NYC's Cholesterol Programs: A Conversation With NYC's Director for CVD Prevention and Control</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black23-NYCCholesterol.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black23-NYCCholesterol.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video commentary with Sonia Angell, MD, New York City's Director for CVD Prevention and Control, Dr. Black discusses the City's program for controlling cholesterol levels in the community. </description>
      <pubDate>Fri, 24 Oct 2008 05:55:00 GMT</pubDate>
      <itunes:subtitle>NYC's Cholesterol Programs: A Conversation With NYC's Director for CVD Prevention and Control</itunes:subtitle>
      <itunes:summary>In this video commentary with Sonia Angell, MD, New York City's Director for CVD Prevention and Control, Dr. Black discusses the City's program for controlling cholesterol levels in the community. </itunes:summary>
      <itunes:keywords>atherosclerotic cardiovascular disease,arteriosclerosis,arteriosclerotic,ascvd,atherosclerotic coronary vessel disease,cardiovascular,disease,disorder, coronary artery disease,CAD,arteries,arteriosclerosis,arteriosclerotic,artery,atherosclerosis,atheroscl</itunes:keywords>
      <itunes:duration>00:04:58</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black23-NYCCholesterol.mp4" length="33659290" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black23-NYCCholesterol.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>NYC's Antihypertension Programs: A Conversation With NYC's Director for CVD Prevention and Control</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black22-NYCHypertension.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black22-NYCHypertension.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video commentary with Sonia Angell, MD, New York City's Director for CVD Prevention and Control, Dr. Black discusses the City's program for supporting clinicians working to control HTN. </description>
      <pubDate>Fri, 24 Oct 2008 05:59:00 GMT</pubDate>
      <itunes:subtitle>NYC's Antihypertension Programs: A Conversation With NYC's Director for CVD Prevention and Control</itunes:subtitle>
      <itunes:summary>In this video commentary with Sonia Angell, MD, New York City's Director for CVD Prevention and Control, Dr. Black discusses the City's program for supporting clinicians working to control HTN. </itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, patient education,behavior,consumer,counseling,counselling,health, preventive care,preventative care,medicine,prevention, </itunes:keywords>
      <itunes:duration>00:03:54</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black22-NYCHypertension.mp4" length="26424115" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black22-NYCHypertension.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Reducing GI Risks of Antiplatelet Therapy and NSAID Use</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-Vblog-AntiplateletTherapy-Johnson09.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-Vblog-AntiplateletTherapy-Johnson09.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his next video blog, Dr. Johnson discusses consensus between GIs and cardiologists on best practice for assessing/balancing cardiovascular and GI risks in patients who need antiplatelet therapy. </description>
      <pubDate>Fri, 24 Oct 2008 06:02:00 GMT</pubDate>
      <itunes:subtitle>Reducing GI Risks of Antiplatelet Therapy and NSAID Use</itunes:subtitle>
      <itunes:summary>In his next video blog, Dr. Johnson discusses consensus between GIs and cardiologists on best practice for assessing/balancing cardiovascular and GI risks in patients who need antiplatelet therapy. </itunes:summary>
      <itunes:keywords>gastrointestinal hemorrhage,GI bleeding,hemorrhage gastrointestinal,b,bleed,hemorrhages,hemorrhagic,i,internal,intestinal, </itunes:keywords>
      <itunes:duration>00:05:42</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-Vblog-AntiplateletTherapy-Johnson09.mp4" length="35127296" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-Vblog-AntiplateletTherapy-Johnson09.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>The Potential Utility of BMSC Transplantation in Chronic Paraplegics</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro08-ParaplegicPigs.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro08-ParaplegicPigs.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog Ron Shapiro, MD discusses a fascinating study of progressive functional recovery in paraplegic pigs after autologous BMSC transplantation. </description>
      <pubDate>Mon, 27 Oct 2008 06:06:00 GMT</pubDate>
      <itunes:subtitle>The Potential Utility of BMSC Transplantation in Chronic Paraplegics</itunes:subtitle>
      <itunes:summary>In this video blog Ron Shapiro, MD discusses a fascinating study of progressive functional recovery in paraplegic pigs after autologous BMSC transplantation. </itunes:summary>
      <itunes:keywords></itunes:keywords>
      <itunes:duration>00:01:25</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro08-ParaplegicPigs.mp4" length="9332326" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro08-ParaplegicPigs.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Ten Years After: PDE-5 Inhibitors at the End of a Decade</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/URO-vblog-Carson03-PDE5i.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/URO-vblog-Carson03-PDE5i.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Dr. Culley Carson offers his thoughts on the 10th year anniversary of the introduction of PDE-5 inhibitors, including the use of these agents in indications other than erectile dysfunction. </description>
      <pubDate>Mon, 27 Oct 2008 06:10:00 GMT</pubDate>
      <itunes:subtitle>Ten Years After: PDE-5 Inhibitors at the End of a Decade</itunes:subtitle>
      <itunes:summary>Dr. Culley Carson offers his thoughts on the 10th year anniversary of the introduction of PDE-5 inhibitors, including the use of these agents in indications other than erectile dysfunction. </itunes:summary>
      <itunes:keywords>erectile dysfunction,difficultly,disfunction, Phosphodiesterase Inhibitors,inhibiter,inhibitor, </itunes:keywords>
      <itunes:duration>00:04:23</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/URO-vblog-Carson03-PDE5i.mp4" length="29569843" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/URO-vblog-Carson03-PDE5i.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Benefactors of the Financial Crisis: Mosquitoes and West Nile Virus</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis04-WestNileVirus.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis04-WestNileVirus.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Lisa Maragakis, MD, MPH, discusses in her video blog a link between an outbreak of human West Nile virus and standing water at foreclosed homes in the area. </description>
      <pubDate>Wed, 29 Oct 2008 06:15:00 GMT</pubDate>
      <itunes:subtitle>Benefactors of the Financial Crisis: Mosquitoes and West Nile Virus</itunes:subtitle>
      <itunes:summary>Lisa Maragakis, MD, MPH, discusses in her video blog a link between an outbreak of human West Nile virus and standing water at foreclosed homes in the area. </itunes:summary>
      <itunes:keywords>insect bite,bites,bug, infectious disease,diseases,disorder,id, West Nile virus West Nile encephalitis, </itunes:keywords>
      <itunes:duration>00:02:46</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis04-WestNileVirus.mp4" length="18350080" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis04-WestNileVirus.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Two Primaries or Metastatic Disease?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ONC-VBlog-Markman16-GynCancer.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ONC-VBlog-Markman16-GynCancer.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his latest video blog, Dr. Maurie Markman discusses advances in the process of determining whether synchronous malignant findings represent 2 unrelated primary cancers or metastatic disease. </description>
      <pubDate>Wed, 29 Oct 2008 06:58:00 GMT</pubDate>
      <itunes:subtitle>Two Primaries or Metastatic Disease?</itunes:subtitle>
      <itunes:summary>In his latest video blog, Dr. Maurie Markman discusses advances in the process of determining whether synchronous malignant findings represent 2 unrelated primary cancers or metastatic disease. </itunes:summary>
      <itunes:keywords>neoplasm malignant ovary,adenocarcinoma,adenocarcinomas,ca,cancer,carcinoma,carcinomas,malignancy,malignant neoplasm,neoplasms,ovarian,ovaries, neoplasm malignant,adenocarcinoma,adenocarcinomas,cancer,neoplasia,neoplasias,neoplasms, carcinoma endometrium,</itunes:keywords>
      <itunes:duration>00:02:40</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ONC-VBlog-Markman16-GynCancer.mp4" length="18035507" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ONC-VBlog-Markman16-GynCancer.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Concierge Medical Practice</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-ConciergeMedicalPractice.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-ConciergeMedicalPractice.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>For whom do we concierge? </description>
      <pubDate>Thu, 30 Oct 2008 07:22:00 GMT</pubDate>
      <itunes:subtitle>Concierge Medical Practice</itunes:subtitle>
      <itunes:summary>For whom do we concierge? </itunes:summary>
      <itunes:keywords>health care costs,expenditure,expenditures,health,healthcare, health care reform,healthcare, health services accessibility, insurance health, health services, quality of health care,healthcare, health care access,healthcare, </itunes:keywords>
      <itunes:duration>00:03:32</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-ConciergeMedicalPractice.mp4" length="23068672" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/FM-vblogs-Morrow-ConciergeMedicalPractice.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Kaunitz on Women's Health: Vitamin D -- Not Just for Bones</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Videoblog-Kaunitz04-VitaminD.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Videoblog-Kaunitz04-VitaminD.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Andrew Kaunitz's Gyn Video Blog: find out about the myriad of positive ways that vitamin D contributes to health. </description>
      <pubDate>Tue, 04 Nov 2008 07:25:00 GMT</pubDate>
      <itunes:subtitle>Kaunitz on Women's Health: Vitamin D -- Not Just for Bones</itunes:subtitle>
      <itunes:summary>Andrew Kaunitz's Gyn Video Blog: find out about the myriad of positive ways that vitamin D contributes to health. </itunes:summary>
      <itunes:keywords>osteoporosis,osteoporotic, osteoporosis risk,osteoporotic,unspecified, neoplasm malignant breast,adenocarcinoma,adenocarcinomas,breasts,ca,cancer,carcinoma,carcinomas,female,malignancy,malignant neoplasm,mammary,neoplasms,woman,women, neoplasm malignant,a</itunes:keywords>
      <itunes:duration>00:03:22</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Videoblog-Kaunitz04-VitaminD.mp4" length="21181235" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Videoblog-Kaunitz04-VitaminD.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Adjuvant Treatment May Not Be Right for All Patients</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall5-MysteryofMSI.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall5-MysteryofMSI.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. John Marshall talks about microsatellite instability, a marker that may reveal which patients with early colorectal cancer should forgo standard adjuvant treatment. </description>
      <pubDate>Wed, 05 Nov 2008 07:28:00 GMT</pubDate>
      <itunes:subtitle>Adjuvant Treatment May Not Be Right for All Patients</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. John Marshall talks about microsatellite instability, a marker that may reveal which patients with early colorectal cancer should forgo standard adjuvant treatment. </itunes:summary>
      <itunes:keywords>neoplasm malignant,adenocarcinoma,adenocarcinomas,cancer,neoplasia,neoplasias,neoplasms, chemotherapy adjuvant, </itunes:keywords>
      <itunes:duration>00:03:44</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall5-MysteryofMSI.mp4" length="26004685" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall5-MysteryofMSI.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Two Authorities Discuss Resistant Hypertension and Spironolactone</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-ResistantHTN-Black24.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-ResistantHTN-Black24.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video conversation, Dr. Black talks with Domenic Sica, MD, about how clinicians do -- or should -- define, recognize, and treat the resistant hypertension patient. </description>
      <pubDate>Wed, 05 Nov 2008 07:40:00 GMT</pubDate>
      <itunes:subtitle>Two Authorities Discuss Resistant Hypertension and Spironolactone</itunes:subtitle>
      <itunes:summary>In this video conversation, Dr. Black talks with Domenic Sica, MD, about how clinicians do -- or should -- define, recognize, and treat the resistant hypertension patient. </itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, hypertension uncontrolled,control,controlled,healthy,high blood pressure,inadequate,poor,poorly,well, </itunes:keywords>
      <itunes:duration>00:10:15</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-ResistantHTN-Black24.mp4" length="69940019" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-ResistantHTN-Black24.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>The New Results From the TRANSCEND and PROFESS Trials</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-VBlog-TranscendandProfess-Black25.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-VBlog-TranscendandProfess-Black25.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video commentary, Dr. Black discusses TRANSCEND, a follow-on subset of ONTARGET, and PROFESS, for secondary stroke prevention -- both trials testing the ARB telmisartan on a randomized basis. </description>
      <pubDate>Wed, 05 Nov 2008 07:43:00 GMT</pubDate>
      <itunes:subtitle>The New Results From the TRANSCEND and PROFESS Trials</itunes:subtitle>
      <itunes:summary>In this video commentary, Dr. Black discusses TRANSCEND, a follow-on subset of ONTARGET, and PROFESS, for secondary stroke prevention -- both trials testing the ARB telmisartan on a randomized basis. </itunes:summary>
      <itunes:keywords></itunes:keywords>
      <itunes:duration>00:04:02</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-VBlog-TranscendandProfess-Black25.mp4" length="28206694" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-VBlog-TranscendandProfess-Black25.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>The Delicate Balance Between Hope and Reality</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall06-IneffectiveTherapy.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall06-IneffectiveTherapy.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>How can clinicians help patients maintain hope, even when further treatments are unlikely to be of benefit? In this video blog, Dr. John Marshall asks when is it time to have the &#34;talk&#34;? </description>
      <pubDate>Tue, 18 Nov 2008 04:16:00 GMT</pubDate>
      <itunes:subtitle>The Delicate Balance Between Hope and Reality</itunes:subtitle>
      <itunes:summary>How can clinicians help patients maintain hope, even when further treatments are unlikely to be of benefit? In this video blog, Dr. John Marshall asks when is it time to have the &#34;talk&#34;? </itunes:summary>
      <itunes:keywords>neoplasm malignant,adenocarcinoma,adenocarcinomas,cancer,neoplasia,neoplasias,neoplasms, death and dying, financing, </itunes:keywords>
      <itunes:duration>00:05:18</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall06-IneffectiveTherapy.mp4" length="35966157" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall06-IneffectiveTherapy.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Ten-Year Follow-up of the UKPDS Trial: The Glucose Control Arm</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black26-UKPDSglucose.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black26-UKPDSglucose.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video commentary Dr. Black discusses the &#34;legacy effect&#34; -- what happened in those patients followed for 10 years after tight glucose control ended with the conclusion of the UKPDS? </description>
      <pubDate>Tue, 18 Nov 2008 04:20:00 GMT</pubDate>
      <itunes:subtitle>Ten-Year Follow-up of the UKPDS Trial: The Glucose Control Arm</itunes:subtitle>
      <itunes:summary>In this video commentary Dr. Black discusses the &#34;legacy effect&#34; -- what happened in those patients followed for 10 years after tight glucose control ended with the conclusion of the UKPDS? </itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, hypertension controlled,blood pressure,bp,control,fair,good,healthy,under,well, diabetes mellitus,DM,diabetes,mellitus,sugar, glucose intolerance,impaired glucose tolerance,glucoses,impairment,into</itunes:keywords>
      <itunes:duration>00:03:09</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black26-UKPDSglucose.mp4" length="21076378" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black26-UKPDSglucose.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Ten-Year Follow-up of the UKPDS Trial: The Blood Pressure Control Arm</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black27-UKPDS-HTN.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black27-UKPDS-HTN.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video commentary Dr Black discusses what hypertensionologists must take away from the 10-year follow-up of UKPDS: what happened in the hypertensive patients after the conclusion of UKPDS? </description>
      <pubDate>Tue, 18 Nov 2008 04:23:00 GMT</pubDate>
      <itunes:subtitle>Ten-Year Follow-up of the UKPDS Trial: The Blood Pressure Control Arm</itunes:subtitle>
      <itunes:summary>In this video commentary Dr Black discusses what hypertensionologists must take away from the 10-year follow-up of UKPDS: what happened in the hypertensive patients after the conclusion of UKPDS? </itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, diabetes mellitus,DM,diabetes,mellitus,sugar, glucose intolerance,impaired glucose tolerance,glucoses,impairment,intolerant, increased blood pressure,elevated blood pressure,bp, </itunes:keywords>
      <itunes:duration>00:03:56</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black27-UKPDS-HTN.mp4" length="26109542" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black27-UKPDS-HTN.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>From ASN 2008: Use of IV Iron in CKD Patients</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-Vblog-Berns06-IroninCKD.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-Vblog-Berns06-IroninCKD.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Jeffrey Berns, MD, from the University of Pennsylvania School of Medicine, discusses IV iron and serum ferritin levels after chairing a session on iron management at the 2008 ASN in this video blog. </description>
      <pubDate>Tue, 18 Nov 2008 04:26:00 GMT</pubDate>
      <itunes:subtitle>From ASN 2008: Use of IV Iron in CKD Patients</itunes:subtitle>
      <itunes:summary>Jeffrey Berns, MD, from the University of Pennsylvania School of Medicine, discusses IV iron and serum ferritin levels after chairing a session on iron management at the 2008 ASN in this video blog. </itunes:summary>
      <itunes:keywords>chronic renal failure,renal failure chronic,renal insufficiency chronic,crf,kidney, anemia iron deficiency,iron deficiency anemia,def,deficient,fe,low blood count, hemodialysis,dialysis,kidney,renal, renal disease,kidney disease,nephrosis,difficultly,diso</itunes:keywords>
      <itunes:duration>00:03:08</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-Vblog-Berns06-IroninCKD.mp4" length="21181235" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-Vblog-Berns06-IroninCKD.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>World Diabetes Day 2008</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-Vblog07-Peters-WorldDiabetesDay.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-Vblog07-Peters-WorldDiabetesDay.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In her latest video blog, Anne Peters, MD, discusses the primary global awareness campaign for the over 250 million patients with diabetes worldwide. </description>
      <pubDate>Tue, 18 Nov 2008 04:29:00 GMT</pubDate>
      <itunes:subtitle>World Diabetes Day 2008</itunes:subtitle>
      <itunes:summary>In her latest video blog, Anne Peters, MD, discusses the primary global awareness campaign for the over 250 million patients with diabetes worldwide. </itunes:summary>
      <itunes:keywords>diabetes insipidus, diabetes mellitus,DM,diabetes,mellitus,sugar, diabetes mellitus type I,juvenile onset diabetes,dependent,dm,iddm,insulin,insulin dependent diabetes mellitus, diabetes mellitus type II uncontrolled,control,controlled,diabetes,dm,mellitu</itunes:keywords>
      <itunes:duration>00:03:14</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-Vblog07-Peters-WorldDiabetesDay.mp4" length="22020096" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-Vblog07-Peters-WorldDiabetesDay.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Priapism: Some New Management Techniques</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/URO-vblog-Carson04-Priapism.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/URO-vblog-Carson04-Priapism.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>While attending the Fall meeting of the Sexual Medicine Society of North America in Toronto, Dr. Carson learned some new techniques for managing priapism. He shares them here in his video blog. </description>
      <pubDate>Tue, 18 Nov 2008 04:43:00 GMT</pubDate>
      <itunes:subtitle>Priapism: Some New Management Techniques</itunes:subtitle>
      <itunes:summary>While attending the Fall meeting of the Sexual Medicine Society of North America in Toronto, Dr. Carson learned some new techniques for managing priapism. He shares them here in his video blog. </itunes:summary>
      <itunes:keywords>sexual dysfunction,difficultly,difficulty,disfunction,problem,problems,sex, sexual dysfunction male,difficultly,man,sex, urology, </itunes:keywords>
      <itunes:duration>00:05:14</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/URO-vblog-Carson04-Priapism.mp4" length="34603008" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/URO-vblog-Carson04-Priapism.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Demanding Highest Standards for New Cancer Diagnostics</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman17-OvarianCancer.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman17-OvarianCancer.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>New cancer diagnostics, such as a recently marketed test for ovarian cancer, should be held to the same rigorous standards as cancer therapeutics, according to Dr. Maurie Markman's latest video blog. </description>
      <pubDate>Thu, 20 Nov 2008 04:45:00 GMT</pubDate>
      <itunes:subtitle>Demanding Highest Standards for New Cancer Diagnostics</itunes:subtitle>
      <itunes:summary>New cancer diagnostics, such as a recently marketed test for ovarian cancer, should be held to the same rigorous standards as cancer therapeutics, according to Dr. Maurie Markman's latest video blog. </itunes:summary>
      <itunes:keywords>neoplasm malignant ovary,adenocarcinoma,adenocarcinomas,ca,cancer,carcinoma,carcinomas,malignancy,malignant neoplasm,neoplasms,ovarian,ovaries, neoplasm malignant,adenocarcinoma,adenocarcinomas,cancer,neoplasia,neoplasias,neoplasms, women\'s health, women</itunes:keywords>
      <itunes:duration>00:02:21</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman17-OvarianCancer.mp4" length="15728640" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman17-OvarianCancer.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Helicobacter pylori: Friend and Foe?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-VBLOG-Auwaerter08-HelicobacterPylori.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-VBLOG-Auwaerter08-HelicobacterPylori.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>How do we reach across the aisle? Paul Auwaerter, MD, MBA, discusses the tenuous nature of the important relationship with the H pylori pathogen in his video blog. </description>
      <pubDate>Thu, 20 Nov 2008 04:47:00 GMT</pubDate>
      <itunes:subtitle>Helicobacter pylori: Friend and Foe?</itunes:subtitle>
      <itunes:summary>How do we reach across the aisle? Paul Auwaerter, MD, MBA, discusses the tenuous nature of the important relationship with the H pylori pathogen in his video blog. </itunes:summary>
      <itunes:keywords>gastric ulcer,disease,disorder,stomach,ulcers, duodenal ulcer,disease,disorder,ulcers, endoscopy,endoscopic,endoscopies,procedure, Helicobacter pylori, pharmacotherapy, </itunes:keywords>
      <itunes:duration>00:05:07</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-VBLOG-Auwaerter08-HelicobacterPylori.mp4" length="31352422" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-VBLOG-Auwaerter08-HelicobacterPylori.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Colon Cancer Screening: An Age to Start and an Age to Stop?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson10-ColonCancerScreening.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson10-ColonCancerScreening.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his next video blog, Dr. Johnson provides commentary on updated guidelines from the US Preventive Services Task Force on screening for colorectal cancer.</description>
      <pubDate>Tue, 25 Nov 2008 10:02:00 GMT</pubDate>
      <itunes:subtitle>Colon Cancer Screening: An Age to Start and an Age to Stop?</itunes:subtitle>
      <itunes:summary>In his next video blog, Dr. Johnson provides commentary on updated guidelines from the US Preventive Services Task Force on screening for colorectal cancer.</itunes:summary>
      <itunes:keywords>disease screening,disorder,preventative,preventive,screenings, colon screening,gastrointestinal,gi,routine,screenings, guidelines, treatment guidelines,tx, </itunes:keywords>
      <itunes:duration>00:04:59</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson10-ColonCancerScreening.mp4" length="33239859" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson10-ColonCancerScreening.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Adverse Events of LTBI Therapy &#38; Postthrombotic Syndrome After Acute DVT</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-Vblog-Shorr09-PulmonaryUpdate.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-Vblog-Shorr09-PulmonaryUpdate.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>This video blog by Dr. Andrew Shorr discusses adverse events of therapy for LTBI and postthrombotic syndrome after acute DVT. </description>
      <pubDate>Tue, 25 Nov 2008 10:05:00 GMT</pubDate>
      <itunes:subtitle>Adverse Events of LTBI Therapy &#38; Postthrombotic Syndrome After Acute DVT</itunes:subtitle>
      <itunes:summary>This video blog by Dr. Andrew Shorr discusses adverse events of therapy for LTBI and postthrombotic syndrome after acute DVT. </itunes:summary>
      <itunes:keywords>deep venous thrombophlebitis,DVT,deep vein thrombosis,phlebitis,thromboembolic,thromboembolism,thromboembolus,thrombosis, tuberculosis,consumption,tb,tuberculous, thrombosis,blood,clot,thromboses, </itunes:keywords>
      <itunes:duration>00:04:10</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-Vblog-Shorr09-PulmonaryUpdate.mp4" length="27158118" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-Vblog-Shorr09-PulmonaryUpdate.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>How Well Did Renal Fellowship Prepare You?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns07-RenalFellowshipExperience.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns07-RenalFellowshipExperience.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Jeffrey S. Berns, MD, from the University of Pennsylvania School of Medicine, discusses the value and impact of renal fellowship training in this video blog. Do you feel your training was adequate? </description>
      <pubDate>Tue, 25 Nov 2008 10:08:00 GMT</pubDate>
      <itunes:subtitle>How Well Did Renal Fellowship Prepare You?</itunes:subtitle>
      <itunes:summary>Jeffrey S. Berns, MD, from the University of Pennsylvania School of Medicine, discusses the value and impact of renal fellowship training in this video blog. Do you feel your training was adequate? </itunes:summary>
      <itunes:keywords>chronic renal failure,renal failure chronic,renal insufficiency chronic,crf,kidney, renal disease,kidney disease,nephrosis,difficultly,disorder,disorders,dysfunction,nephropathy, fellowship,fellow,fellows, </itunes:keywords>
      <itunes:duration>00:01:58</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns07-RenalFellowshipExperience.mp4" length="12268339" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns07-RenalFellowshipExperience.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>The Pill: Indispensable for Women...But Not for Everyone</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz05-ThePill.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz05-ThePill.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Obesity has emerged as an important risk factor for women older than age 35 who use oral contraceptives. </description>
      <pubDate>Tue, 25 Nov 2008 10:10:00 GMT</pubDate>
      <itunes:subtitle>The Pill: Indispensable for Women...But Not for Everyone</itunes:subtitle>
      <itunes:summary>Obesity has emerged as an important risk factor for women older than age 35 who use oral contraceptives. </itunes:summary>
      <itunes:keywords>obesity,overweight,adiposity,obese,weight, neoplasm malignant breast,adenocarcinoma,adenocarcinomas,breasts,ca,cancer,carcinoma,carcinomas,female,malignancy,malignant neoplasm,mammary,neoplasms,woman,women, weight loss,losing,reduction,weigh,wt, women&#38;s </itunes:keywords>
      <itunes:duration>00:04:15</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz05-ThePill.mp4" length="27996979" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz05-ThePill.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Improving Diagnosis in Pediatric Schizophrenia</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling07-AccurateDiagnosisofSchizophrenia.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling07-AccurateDiagnosisofSchizophrenia.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>What steps can clinicians take to definitively identify schizophrenia in young patients? In his latest video blog, Dr. Robert Findling discusses a thorough approach. </description>
      <pubDate>Wed, 26 Nov 2008 10:12:00 GMT</pubDate>
      <itunes:subtitle>Improving Diagnosis in Pediatric Schizophrenia</itunes:subtitle>
      <itunes:summary>What steps can clinicians take to definitively identify schizophrenia in young patients? In his latest video blog, Dr. Robert Findling discusses a thorough approach. </itunes:summary>
      <itunes:keywords>schizophrenia,schizophrenic, </itunes:keywords>
      <itunes:duration>00:04:04</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling07-AccurateDiagnosisofSchizophrenia.mp4" length="27367834" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling07-AccurateDiagnosisofSchizophrenia.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Combining IVIG and Rituximab to Treat Chronic Renal Allograft Rejection</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro09-IVGandRituximab.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro09-IVGandRituximab.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog Ron Shapiro, MD discusses the results of a pilot study of the treatment of chronic antibody-mediated rejection in pediatric renal transplant recipients. </description>
      <pubDate>Mon, 01 Dec 2008 10:16:00 GMT</pubDate>
      <itunes:subtitle>Combining IVIG and Rituximab to Treat Chronic Renal Allograft Rejection</itunes:subtitle>
      <itunes:summary>In this video blog Ron Shapiro, MD discusses the results of a pilot study of the treatment of chronic antibody-mediated rejection in pediatric renal transplant recipients. </itunes:summary>
      <itunes:keywords>kidney transplantation,allograft,renal,transplant,transplants, transplant rejection chronic,transplants, transplantation, </itunes:keywords>
      <itunes:duration>00:01:08</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro09-IVGandRituximab.mp4" length="7340032" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro09-IVGandRituximab.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Manageable Cardiac Toxicities Do Not Reduce Benefits of Targeted Therapies in Renal Cell Carcinoma</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman18-RenalCellCarcinoma.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman18-RenalCellCarcinoma.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Although cardiac toxicities are common with sunitinib and sorafenib, in this video blog, Dr. Maurie Markman notes that early intervention can prevent negative effects on outcomes. </description>
      <pubDate>Wed, 03 Dec 2008 06:34:00 GMT</pubDate>
      <itunes:subtitle>Manageable Cardiac Toxicities Do Not Reduce Benefits of Targeted Therapies in Renal Cell Carcinoma</itunes:subtitle>
      <itunes:summary>Although cardiac toxicities are common with sunitinib and sorafenib, in this video blog, Dr. Maurie Markman notes that early intervention can prevent negative effects on outcomes. </itunes:summary>
      <itunes:keywords>chemotherapy, carcinoma renal cell,ca,carcinomas,kidney, oncology, toxicology, </itunes:keywords>
      <itunes:duration>00:02:12</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman18-RenalCellCarcinoma.mp4" length="14575206" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman18-RenalCellCarcinoma.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Fever in Stroke and Other Brain Injuries Is Associated With Worse Outcomes</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-Vblog-Alberts05-Stroke.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-Vblog-Alberts05-Stroke.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>See Dr Albert&#39;s video blog on fever associated with worse outcomes in stroke and other brain injuries, a meta-analysis study by Greer and colleagues published in the November 2008 issue of Stroke. </description>
      <pubDate>Thu, 04 Dec 2008 06:36:00 GMT</pubDate>
      <itunes:subtitle>Fever in Stroke and Other Brain Injuries Is Associated With Worse Outcomes</itunes:subtitle>
      <itunes:summary>See Dr Albert&#39;s video blog on fever associated with worse outcomes in stroke and other brain injuries, a meta-analysis study by Greer and colleagues published in the November 2008 issue of Stroke. </itunes:summary>
      <itunes:keywords>fever,fevers, </itunes:keywords>
      <itunes:duration>00:03:30</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-Vblog-Alberts05-Stroke.mp4" length="24222106" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-Vblog-Alberts05-Stroke.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Updated ADA Guidelines for Treating Type 2 Diabetes</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-Vblog08-Peters-NewADAGuidelines.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-Vblog08-Peters-NewADAGuidelines.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In her latest video blog, Dr. Peters discusses the new ADA recommendations for treating type 2 diabetes. </description>
      <pubDate>Thu, 04 Dec 2008 06:39:00 GMT</pubDate>
      <itunes:subtitle>Updated ADA Guidelines for Treating Type 2 Diabetes</itunes:subtitle>
      <itunes:summary>In her latest video blog, Dr. Peters discusses the new ADA recommendations for treating type 2 diabetes. </itunes:summary>
      <itunes:keywords>diabetes mellitus type II,adult,depend,dependant,dependent,diabetes,diabetic,dm,insulin,mellitus,niddm,non,non insulin dependent diabetes mellitus,noninsulin,onset,requiring,uncomplicated, hyperglycemia,bg,blood,blood glucose,elevated,elevated glucose,hig</itunes:keywords>
      <itunes:duration>00:03:17</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-Vblog08-Peters-NewADAGuidelines.mp4" length="22334669" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Diab-Vblog08-Peters-NewADAGuidelines.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Bortezomib Shows Promise for Treatment of Antibody-Mediated Rejection In Renal Transplantation</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro10-Bortezomib.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro10-Bortezomib.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog Ron Shapiro, MD discusses emerging data on the proteasome inhibitor bortezomib, a chemotherapeutic agent that targets plasma cells, for treatment of humoral rejection. </description>
      <pubDate>Mon, 08 Dec 2008 06:43:00 GMT</pubDate>
      <itunes:subtitle>Bortezomib Shows Promise for Treatment of Antibody-Mediated Rejection In Renal Transplantation</itunes:subtitle>
      <itunes:summary>In this video blog Ron Shapiro, MD discusses emerging data on the proteasome inhibitor bortezomib, a chemotherapeutic agent that targets plasma cells, for treatment of humoral rejection. </itunes:summary>
      <itunes:keywords>kidney transplantation,allograft,renal,transplant,transplants, transplant rejection acute,transplants, graft rejection, transplantation, vascular rejection, </itunes:keywords>
      <itunes:duration>00:01:27</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro10-Bortezomib.mp4" length="9542042" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro10-Bortezomib.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Quantum Jumps in Human Genome Sequencing</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Genome-vblog-Topol10-HumanGenomeSequencing.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Genome-vblog-Topol10-HumanGenomeSequencing.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this videoblog, Dr. Eric Topol discusses 3 papers in Nature that may signify a revolution in comprehensive DNA sequencing. </description>
      <pubDate>Fri, 19 Dec 2008 07:04:00 GMT</pubDate>
      <itunes:subtitle>Quantum Jumps in Human Genome Sequencing</itunes:subtitle>
      <itunes:summary>In this videoblog, Dr. Eric Topol discusses 3 papers in Nature that may signify a revolution in comprehensive DNA sequencing. </itunes:summary>
      <itunes:keywords>leukemia, genomics, pharmacogenomics, </itunes:keywords>
      <itunes:duration>00:03:23</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Genome-vblog-Topol10-HumanGenomeSequencing.mp4" length="21705523" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Genome-vblog-Topol10-HumanGenomeSequencing.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Real-World Results Are Often Better Than Clinical Trials Suggest</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall07-Bevacizumab.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall07-Bevacizumab.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. John Marshall reflects on new data and evolving experience with bevacizumab in real patients with colorectal cancer. </description>
      <pubDate>Mon, 08 Dec 2008 07:10:00 GMT</pubDate>
      <itunes:subtitle>Real-World Results Are Often Better Than Clinical Trials Suggest</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. John Marshall reflects on new data and evolving experience with bevacizumab in real patients with colorectal cancer. </itunes:summary>
      <itunes:keywords>neoplasm malignant,adenocarcinoma,adenocarcinomas,cancer,neoplasia,neoplasias,neoplasms, thromboembolism,thromboembolic,thromboembolus, metastasis,disease,disorder,metastases,metastatic, colon,bowel,intestine,large, </itunes:keywords>
      <itunes:duration>00:06:12</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall07-Bevacizumab.mp4" length="41313894" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall07-Bevacizumab.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Kaunitz on Women&#39;s Health: Obesity and the Risk for Advanced Breast Cancer: Another Reason to Lose Weight</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz06-ObesityandBreastCancer.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz06-ObesityandBreastCancer.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>What variables might account for differences in risk for advanced breast cancer between obese and nonobese women? </description>
      <pubDate>Mon, 15 Dec 2008 07:13:00 GMT</pubDate>
      <itunes:subtitle>Kaunitz on Women&#39;s Health: Obesity and the Risk for Advanced Breast Cancer: Another Reason to Lose Weight</itunes:subtitle>
      <itunes:summary>What variables might account for differences in risk for advanced breast cancer between obese and nonobese women? </itunes:summary>
      <itunes:keywords>obesity,overweight,adiposity,obese,weight, neoplasm malignant breast,adenocarcinoma,adenocarcinomas,breasts,ca,cancer,carcinoma,carcinomas,female,malignancy,malignant neoplasm,mammary,neoplasms,woman,women, weight loss,losing,reduction,weigh,wt, women&#39;</itunes:keywords>
      <itunes:duration>00:03:40</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz06-ObesityandBreastCancer.mp4" length="23907533" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz06-ObesityandBreastCancer.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>A Summary of the Revision to DHHS HIV Treatment Guidelines</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HIV-Vblog-Sax01-DHSGuidelines.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HIV-Vblog-Sax01-DHSGuidelines.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his first Medscape video blog, Dr. Sax provides a summary of the recent changes to the DHHS guidelines for treatment of HIV in adults and adolescents. </description>
      <pubDate>Wed, 17 Dec 2008 04:16:00 GMT</pubDate>
      <itunes:subtitle>A Summary of the Revision to DHHS HIV Treatment Guidelines</itunes:subtitle>
      <itunes:summary>In his first Medscape video blog, Dr. Sax provides a summary of the recent changes to the DHHS guidelines for treatment of HIV in adults and adolescents. </itunes:summary>
      <itunes:keywords>HIV infection,active,aids,arc,disease,disorder,human immunodeficiency virus,infected,infections,pos,positive,status, treatment guidelines,tx, antiretroviral therapy,antiretrovirals, </itunes:keywords>
      <itunes:duration>00:03:05</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HIV-Vblog-Sax01-DHSGuidelines.mp4" length="20552090" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HIV-Vblog-Sax01-DHSGuidelines.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Minimal Hepatic Encephalopathy and Impaired Driving</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson11-MinimalHepaticEncephalopathy.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson11-MinimalHepaticEncephalopathy.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his next video blog, Dr. Johnson provides commentary on a recent article that explores whether patients with minimal hepatic encephalopathy have insight into their impaired driving skills. </description>
      <pubDate>Thu, 18 Dec 2008 04:21:00 GMT</pubDate>
      <itunes:subtitle>Minimal Hepatic Encephalopathy and Impaired Driving</itunes:subtitle>
      <itunes:summary>In his next video blog, Dr. Johnson provides commentary on a recent article that explores whether patients with minimal hepatic encephalopathy have insight into their impaired driving skills. </itunes:summary>
      <itunes:keywords>hepatic cirrhosis,cirrhosis,liver, hepatic disease,disorder,liver, cognitive dysfunction mild,deficit,deficits,difficultly,impairment,mci, encephalopathy,encephalopathic, </itunes:keywords>
      <itunes:duration>00:04:48</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson11-MinimalHepaticEncephalopathy.mp4" length="31771853" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson11-MinimalHepaticEncephalopathy.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Is ESA Loading Beneficial?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns08-ESALoading.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns08-ESALoading.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Jeffrey Berns, MD, from the University of Pennsylvania School of Medicine, discusses the value of ESA loading in hospitalized patients. Does it cause harm or benefit? </description>
      <pubDate>Mon, 22 Dec 2008 04:28:00 GMT</pubDate>
      <itunes:subtitle>Is ESA Loading Beneficial?</itunes:subtitle>
      <itunes:summary>In this video blog, Jeffrey Berns, MD, from the University of Pennsylvania School of Medicine, discusses the value of ESA loading in hospitalized patients. Does it cause harm or benefit? </itunes:summary>
      <itunes:keywords>chronic renal failure,renal failure chronic,renal insufficiency chronic,crf,kidney, renal failure end stage,ESRD,renal disease end stage,anemia,chronic,disorder,end stage renal disease,kidney,low blood count, anemia,low blood count, anemia iron deficiency</itunes:keywords>
      <itunes:duration>00:02:53</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns08-ESALoading.mp4" length="18350080" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns08-ESALoading.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Hypersensitivity to HPV Vaccine Is Uncommon</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman19-HPVVaccination.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman19-HPVVaccination.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. Maurie Markman explains that most reported hypersensitivity reactions purportedly associated with HPV vaccination may not, in fact, be due to actual hypersensitivity. </description>
      <pubDate>Tue, 23 Dec 2008 04:37:00 GMT</pubDate>
      <itunes:subtitle>Hypersensitivity to HPV Vaccine Is Uncommon</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. Maurie Markman explains that most reported hypersensitivity reactions purportedly associated with HPV vaccination may not, in fact, be due to actual hypersensitivity. </itunes:summary>
      <itunes:keywords>immunization,vaccination,immunizations,shots,vaccinations, human papillomavirus,hpv,papilloma,papillomas,papillomata,viral,virus, vaccine preventative,preventive, hypersensitivity allergic, </itunes:keywords>
      <itunes:duration>00:02:47</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman19-HPVVaccination.mp4" length="18979226" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman19-HPVVaccination.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Using an Algorithm to Identify Risk for Chronic Kidney Disease</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns09-AKIScoring.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns09-AKIScoring.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Jeff Berns, MD, from the University of Pennsylvania School of Medicine, discusses the use of an algorithm to predict CKD risk, as detailed in the Dec &#39;08 issue of Arch Intern Med. </description>
      <pubDate>Wed, 24 Dec 2008 04:41:00 GMT</pubDate>
      <itunes:subtitle>Using an Algorithm to Identify Risk for Chronic Kidney Disease</itunes:subtitle>
      <itunes:summary>In this video blog, Jeff Berns, MD, from the University of Pennsylvania School of Medicine, discusses the use of an algorithm to predict CKD risk, as detailed in the Dec &#39;08 issue of Arch Intern Med. </itunes:summary>
      <itunes:keywords>chronic renal failure,renal failure chronic,renal insufficiency chronic,crf,kidney, renal disease,kidney disease,nephrosis,difficultly,disorder,disorders,dysfunction,nephropathy, risk management, </itunes:keywords>
      <itunes:duration>00:02:43</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns09-AKIScoring.mp4" length="17720934" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns09-AKIScoring.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Ambulatory Blood Pressure Monitoring: Special Considerations When Used in Children</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black-ABPMinChildren.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black-ABPMinChildren.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Does ABPM have the same utility in children as it does in adults, and are all variables to diagnose high blood pressure the same? Dr. Henry Black discusses a recent AHA statement on ABPM in children. </description>
      <pubDate>Wed, 31 Dec 2008 04:53:00 GMT</pubDate>
      <itunes:subtitle>Ambulatory Blood Pressure Monitoring: Special Considerations When Used in Children</itunes:subtitle>
      <itunes:summary>Does ABPM have the same utility in children as it does in adults, and are all variables to diagnose high blood pressure the same? Dr. Henry Black discusses a recent AHA statement on ABPM in children. </itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, increased blood pressure,elevated blood pressure,bp, </itunes:keywords>
      <itunes:duration>00:02:31</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black-ABPMinChildren.mp4" length="17196646" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black-ABPMinChildren.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Prosthetic Joint Infections and Propionibacterium acnes: Moving Beyond the Skin?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Auwaerter09-ProstheticJointInfections.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Auwaerter09-ProstheticJointInfections.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Prosthetic joint infections: Learn about new data and the implications for clinical practice. </description>
      <pubDate>Fri, 02 Jan 2009 04:55:00 GMT</pubDate>
      <itunes:subtitle>Prosthetic Joint Infections and Propionibacterium acnes: Moving Beyond the Skin?</itunes:subtitle>
      <itunes:summary>Prosthetic joint infections: Learn about new data and the implications for clinical practice. </itunes:summary>
      <itunes:keywords>prosthesis orthopedic,orthopaedic, infection joint,infected, </itunes:keywords>
      <itunes:duration>00:06:20</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Auwaerter09-ProstheticJointInfections.mp4" length="41523610" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Auwaerter09-ProstheticJointInfections.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>In the Midst of a Beta-Blocker Controversy in Hypertension</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black29-Betablockers.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black29-Betablockers.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>The Scandinavians raised the issue, the British Hypertension Society agreed, and ESH kept beta-blockers as an option. But where does the US stand and what does heart rate have to do with it? </description>
      <pubDate>Fri, 02 Jan 2009 04:58:00 GMT</pubDate>
      <itunes:subtitle>In the Midst of a Beta-Blocker Controversy in Hypertension</itunes:subtitle>
      <itunes:summary>The Scandinavians raised the issue, the British Hypertension Society agreed, and ESH kept beta-blockers as an option. But where does the US stand and what does heart rate have to do with it? </itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, Beta blockers,adrenergic, treatment guidelines,tx, </itunes:keywords>
      <itunes:duration>00:03:44</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black29-Betablockers.mp4" length="25060966" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black29-Betablockers.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Rejection of Cardiac Xenografts in a GalT-KO Pig-to-Baboon Transplant Model</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro11-CardiacXenografts.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro11-CardiacXenografts.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog Ron Shapiro, MD discusses the development of chronic antibody and cell-mediated rejection in baboons receiving heterotopic cardiac xenografts from GalT-KO swine. </description>
      <pubDate>Fri, 02 Jan 2009 05:00:00 GMT</pubDate>
      <itunes:subtitle>Rejection of Cardiac Xenografts in a GalT-KO Pig-to-Baboon Transplant Model</itunes:subtitle>
      <itunes:summary>In this video blog Ron Shapiro, MD discusses the development of chronic antibody and cell-mediated rejection in baboons receiving heterotopic cardiac xenografts from GalT-KO swine. </itunes:summary>
      <itunes:keywords>organ transplantation,transplant,transplants, xenotransplantation,between,species,transplantation, </itunes:keywords>
      <itunes:duration>00:01:57</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro11-CardiacXenografts.mp4" length="12478054" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro11-CardiacXenografts.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Can Percutaneous Renal Biopsy Direct Kidney Allocation in Liver Transplant Candidates With Renal Failure?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro12-KidneyAllocation.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro12-KidneyAllocation.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog Ron Shapiro, MD discusses the results of a study of the feasibility, value, and risk of percutaneous renal biopsy in liver transplant candidates with renal failure. </description>
      <pubDate>Mon, 05 Jan 2009 06:59:00 GMT</pubDate>
      <itunes:subtitle>Can Percutaneous Renal Biopsy Direct Kidney Allocation in Liver Transplant Candidates With Renal Failure?</itunes:subtitle>
      <itunes:summary>In this video blog Ron Shapiro, MD discusses the results of a study of the feasibility, value, and risk of percutaneous renal biopsy in liver transplant candidates with renal failure. </itunes:summary>
      <itunes:keywords>kidney transplantation,allograft,renal,transplant,transplants, organ donation, organ transplantation,transplant,transplants, </itunes:keywords>
      <itunes:duration>00:01:36</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro12-KidneyAllocation.mp4" length="10276045" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro12-KidneyAllocation.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Benefit of Chemoradiation for Cervical Cancer</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman20-neoadjuvantchemo.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman20-neoadjuvantchemo.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Data from 13 trials confirm a 6% improvement in overall survival at 5 years for patients with locally advanced cervical cancer, reports Dr. Maurie Markman in this video blog. </description>
      <pubDate>Mon, 05 Jan 2009 07:06:00 GMT</pubDate>
      <itunes:subtitle>Benefit of Chemoradiation for Cervical Cancer</itunes:subtitle>
      <itunes:summary>Data from 13 trials confirm a 6% improvement in overall survival at 5 years for patients with locally advanced cervical cancer, reports Dr. Maurie Markman in this video blog. </itunes:summary>
      <itunes:keywords>chemotherapy, neoplasm malignant cervix,cervical cancer,adenocarcinoma,adenocarcinomas,ca,carcinoma,carcinomas,endocervical,malignancy,malignant neoplasm,neoplasms, women\'s health, oncology, women\'s health, </itunes:keywords>
      <itunes:duration>00:02:34</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman20-neoadjuvantchemo.mp4" length="17406362" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman20-neoadjuvantchemo.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Which Menopausal Progestational Agent Is Safest?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Vblog-Kaunitz07-MenopausalOestrogen.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Vblog-Kaunitz07-MenopausalOestrogen.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. Andrew Kaunitz discusses use of combination hormone therapy in menopausal women as well as which progestin may pose less risk for breast cancer. </description>
      <pubDate>Wed, 07 Jan 2009 07:12:00 GMT</pubDate>
      <itunes:subtitle>Which Menopausal Progestational Agent Is Safest?</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. Andrew Kaunitz discusses use of combination hormone therapy in menopausal women as well as which progestin may pose less risk for breast cancer. </itunes:summary>
      <itunes:keywords>neoplasm malignant breast,adenocarcinoma,adenocarcinomas,breasts,ca,cancer,carcinoma,carcinomas,female,malignancy,malignant neoplasm,mammary,neoplasms,woman,women, menopausal syndrome,climacteric state female,menopause,status,symptom,symptoms,syndromes,wo</itunes:keywords>
      <itunes:duration>00:03:51</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Vblog-Kaunitz07-MenopausalOestrogen.mp4" length="25690112" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Vblog-Kaunitz07-MenopausalOestrogen.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Lifetime Extension of Medicare Immunosuppression Is Associated with Improved Allograft Survival Among Low-income Transplant Recipients</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro13-KidneyTransplantGraft.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro13-KidneyTransplantGraft.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog Ron Shapiro, MD discusses the cost-effectiveness of lifelong Medicare coverage of immunosuppressive medications for economically disparate renal transplant recipients. </description>
      <pubDate>Mon, 12 Jan 2009 07:17:00 GMT</pubDate>
      <itunes:subtitle>Lifetime Extension of Medicare Immunosuppression Is Associated with Improved Allograft Survival Among Low-income Transplant Recipients</itunes:subtitle>
      <itunes:summary>In this video blog Ron Shapiro, MD discusses the cost-effectiveness of lifelong Medicare coverage of immunosuppressive medications for economically disparate renal transplant recipients. </itunes:summary>
      <itunes:keywords>kidney transplantation,allograft,renal,transplant,transplants, organ transplantation,transplant,transplants, Medicare, drug benefit Medicare,medication, </itunes:keywords>
      <itunes:duration>00:01:37</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro13-KidneyTransplantGraft.mp4" length="10590618" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-vblog-Shapiro13-KidneyTransplantGraft.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>A Behavioral Trick From Public Health Officials -- Making You Make Your Own Dietary Choices</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black32-CalorieCount.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black32-CalorieCount.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Some restaurants in NYC are now required to post calorie counts on menus. Should making salt shakers optional be next in the battle against hypertension? In his video discussion, Henry Black comments. </description>
      <pubDate>Mon, 12 Jan 2009 07:20:00 GMT</pubDate>
      <itunes:subtitle>A Behavioral Trick From Public Health Officials -- Making You Make Your Own Dietary Choices</itunes:subtitle>
      <itunes:summary>Some restaurants in NYC are now required to post calorie counts on menus. Should making salt shakers optional be next in the battle against hypertension? In his video discussion, Henry Black comments. </itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, hypertension instructions,blood pressure,bp,diet,hypertensive,recommendations,teaching,watch, lifestyle recommendations,counseling,counselling,diet,discussed,drug,education,encourage,encouraged,exe</itunes:keywords>
      <itunes:duration>00:02:59</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black32-CalorieCount.mp4" length="20132659" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black32-CalorieCount.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Neoadjuvant Chemotherapy for Advanced Ovarian Cancer: A Reasonable Option?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-Vblog-Markman21-OvarianCancer.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-Vblog-Markman21-OvarianCancer.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. Maurie Markman reports on a study indicating that preoperative chemotherapy is associated with fewer postsurgical deaths and complications compared with standard regimens. </description>
      <pubDate>Fri, 23 Jan 2009 07:24:00 GMT</pubDate>
      <itunes:subtitle>Neoadjuvant Chemotherapy for Advanced Ovarian Cancer: A Reasonable Option?</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. Maurie Markman reports on a study indicating that preoperative chemotherapy is associated with fewer postsurgical deaths and complications compared with standard regimens. </itunes:summary>
      <itunes:keywords>neoplasm malignant ovary,adenocarcinoma,adenocarcinomas,ca,cancer,carcinoma,carcinomas,malignancy,malignant neoplasm,neoplasms,ovarian,ovaries, neoplasm malignant,adenocarcinoma,adenocarcinomas,cancer,neoplasia,neoplasias,neoplasms, chemotherapy, chemothe</itunes:keywords>
      <itunes:duration>00:02:42</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-Vblog-Markman21-OvarianCancer.mp4" length="18035507" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-Vblog-Markman21-OvarianCancer.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>AV Access and Fistula First?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-Vblog-Berns10-AvAccess.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-Vblog-Berns10-AvAccess.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Jeffrey Berns, MD, of UPenn School of Medicine, looks at the wide net cast by new clinical practice guidelines on placement and maintenance of arteriovenous hemodialysis access. </description>
      <pubDate>Wed, 14 Jan 2009 04:47:00 GMT</pubDate>
      <itunes:subtitle>AV Access and Fistula First?</itunes:subtitle>
      <itunes:summary>In this video blog, Jeffrey Berns, MD, of UPenn School of Medicine, looks at the wide net cast by new clinical practice guidelines on placement and maintenance of arteriovenous hemodialysis access. </itunes:summary>
      <itunes:keywords>hemodialysis,dialysis,kidney,renal, renal disease,kidney disease,nephrosis,difficultly,disorder,disorders,dysfunction,nephropathy, </itunes:keywords>
      <itunes:duration>00:03:01</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-Vblog-Berns10-AvAccess.mp4" length="19608371" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-Vblog-Berns10-AvAccess.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Host Response May Be Key to Winning the War on Cancer</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall08-TumourHostInteraction.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall08-TumourHostInteraction.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. John Marshall speculates that understanding and manipulating the host response may yield even greater benefits than current efforts to understand and attack tumors. </description>
      <pubDate>Wed, 14 Jan 2009 04:54:00 GMT</pubDate>
      <itunes:subtitle>Host Response May Be Key to Winning the War on Cancer</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. John Marshall speculates that understanding and manipulating the host response may yield even greater benefits than current efforts to understand and attack tumors. </itunes:summary>
      <itunes:keywords>neoplasm malignant,adenocarcinoma,adenocarcinomas,cancer,neoplasia,neoplasias,neoplasms, oncology, ^, </itunes:keywords>
      <itunes:duration>00:04:30</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall08-TumourHostInteraction.mp4" length="30618419" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall08-TumourHostInteraction.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>What to Do With Diastolic Dysfunction Secondary to Hypertension?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black33-DiastolicDysfunction.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black33-DiastolicDysfunction.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Combined findings from I-PRESERVE and ALLHAT may lend insight into treating this challenging condition. </description>
      <pubDate>Wed, 14 Jan 2009 05:05:00 GMT</pubDate>
      <itunes:subtitle>What to Do With Diastolic Dysfunction Secondary to Hypertension?</itunes:subtitle>
      <itunes:summary>Combined findings from I-PRESERVE and ALLHAT may lend insight into treating this challenging condition. </itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, heart failure,cardiac, </itunes:keywords>
      <itunes:duration>00:03:41</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black33-DiastolicDysfunction.mp4" length="24641536" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-VBlog-Black33-DiastolicDysfunction.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Patent Foramen Ovale and Risk for Recurrent Stroke</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-vblog-Alberts07-PFOUpdate.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-vblog-Alberts07-PFOUpdate.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>A new study casts doubt on the role patent foramen ovale plays in a patient&#39;s risk for recurrent stroke, says Dr. Mark Alberts in this video blog. </description>
      <pubDate>Fri, 16 Jan 2009 05:07:00 GMT</pubDate>
      <itunes:subtitle>Patent Foramen Ovale and Risk for Recurrent Stroke</itunes:subtitle>
      <itunes:summary>A new study casts doubt on the role patent foramen ovale plays in a patient&#39;s risk for recurrent stroke, says Dr. Mark Alberts in this video blog. </itunes:summary>
      <itunes:keywords></itunes:keywords>
      <itunes:duration>00:02:42</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-vblog-Alberts07-PFOUpdate.mp4" length="18350080" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-vblog-Alberts07-PFOUpdate.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Compounding Pharmacies and the Risk of Outbreaks</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis5-PharmaceuticalCompounding.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis5-PharmaceuticalCompounding.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog Lisa L. Maragakis, MD, MPH discusses recent studies highlighting the risks of infectious outbreaks related to compounding pharmacies. </description>
      <pubDate>Fri, 16 Jan 2009 05:18:00 GMT</pubDate>
      <itunes:subtitle>Compounding Pharmacies and the Risk of Outbreaks</itunes:subtitle>
      <itunes:summary>In this video blog Lisa L. Maragakis, MD, MPH discusses recent studies highlighting the risks of infectious outbreaks related to compounding pharmacies. </itunes:summary>
      <itunes:keywords>infectious disease,diseases,disorder,id, pharmacy,pharmacies, </itunes:keywords>
      <itunes:duration>00:03:23</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis5-PharmaceuticalCompounding.mp4" length="26424115" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis5-PharmaceuticalCompounding.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>From ASH 2008: Lower-Toxicity Therapies for Older Adults with AML</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-Vblog-Stone1-AML.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-Vblog-Stone1-AML.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his first Medscape video blog, Dr. Richard Stone reviews resistance mechanisms in older adults with AML and reports on new agents that might be less toxic than the standard &#34;3 + 7&#34; regimen. </description>
      <pubDate>Tue, 20 Jan 2009 05:21:00 GMT</pubDate>
      <itunes:subtitle>From ASH 2008: Lower-Toxicity Therapies for Older Adults with AML</itunes:subtitle>
      <itunes:summary>In his first Medscape video blog, Dr. Richard Stone reviews resistance mechanisms in older adults with AML and reports on new agents that might be less toxic than the standard &#34;3 + 7&#34; regimen. </itunes:summary>
      <itunes:keywords>neoplasm malignant,adenocarcinoma,adenocarcinomas,cancer,neoplasia,neoplasias,neoplasms, leukemia, senior health,adults,concerns,elderly,old age,older,seniors, oncology, geriatric medicine,care,elder,elderly,geriatrics, </itunes:keywords>
      <itunes:duration>00:04:41</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-Vblog-Stone1-AML.mp4" length="29569843" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-Vblog-Stone1-AML.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>JUPITER--the Bottom Line? Measure CRP</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black31-JupiterStudy.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black31-JupiterStudy.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Dr. Henry Black sees the JUPITER study as a major step forward for targeting and treating more accurate those at risk for cardiovascular events. </description>
      <pubDate>Wed, 21 Jan 2009 05:57:00 GMT</pubDate>
      <itunes:subtitle>JUPITER--the Bottom Line? Measure CRP</itunes:subtitle>
      <itunes:summary>Dr. Henry Black sees the JUPITER study as a major step forward for targeting and treating more accurate those at risk for cardiovascular events. </itunes:summary>
      <itunes:keywords>cardiovascular disease,dis,disorder,disorders, preventive care,preventative care,medicine,prevention, </itunes:keywords>
      <itunes:duration>00:05:25</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black31-JupiterStudy.mp4" length="36595302" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black31-JupiterStudy.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Which Menopausal Progestational Agent Is Safest?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Vblog-Kaunitz08-MenopausalHormonalTherapy.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Vblog-Kaunitz08-MenopausalHormonalTherapy.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. Andrew Kaunitz discusses use of combination hormone therapy in menopausal women as well as which progestin may pose less risk for breast cancer. </description>
      <pubDate>Thu, 22 Jan 2009 06:02:00 GMT</pubDate>
      <itunes:subtitle>Which Menopausal Progestational Agent Is Safest?</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. Andrew Kaunitz discusses use of combination hormone therapy in menopausal women as well as which progestin may pose less risk for breast cancer. </itunes:summary>
      <itunes:keywords>neoplasm malignant breast,adenocarcinoma,adenocarcinomas,breasts,ca,cancer,carcinoma,carcinomas,female,malignancy,malignant neoplasm,mammary,neoplasms,woman,women, menopausal syndrome,climacteric state female,menopause,status,symptom,symptoms,syndromes,wo</itunes:keywords>
      <itunes:duration>00:04:59</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Vblog-Kaunitz08-MenopausalHormonalTherapy.mp4" length="33764147" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Vblog-Kaunitz08-MenopausalHormonalTherapy.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Peanut Butter and Salmonella: Not the Perfect Combination</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Auwaerter10-PeanutButterandSalmonella.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Auwaerter10-PeanutButterandSalmonella.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Salmonella and peanut butter -- how should you advise patients with questions? Where can you find the latest information? Paul Auwaerter, MD, offers advice. </description>
      <pubDate>Wed, 28 Jan 2009 03:22:00 GMT</pubDate>
      <itunes:subtitle>Peanut Butter and Salmonella: Not the Perfect Combination</itunes:subtitle>
      <itunes:summary>Salmonella and peanut butter -- how should you advise patients with questions? Where can you find the latest information? Paul Auwaerter, MD, offers advice. </itunes:summary>
      <itunes:keywords>diarrhea,diarrheal,diarrhoea,runs, infectious disease,diseases,disorder,id, </itunes:keywords>
      <itunes:duration>00:04:46</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Auwaerter10-PeanutButterandSalmonella.mp4" length="32715571" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Auwaerter10-PeanutButterandSalmonella.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Colonoscopy Controversies -- Challenges to the Gold Standard?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson12-ColonoscopyControversies.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson12-ColonoscopyControversies.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>David A. Johnson, MD, FACG, FASGE, FACP talks about why colonoscopy is still the preferred strategy for CRC prevention. Who should do the procedure? What new information do the latest studies offer? </description>
      <pubDate>Thu, 29 Jan 2009 03:25:00 GMT</pubDate>
      <itunes:subtitle>Colonoscopy Controversies -- Challenges to the Gold Standard?</itunes:subtitle>
      <itunes:summary>David A. Johnson, MD, FACG, FASGE, FACP talks about why colonoscopy is still the preferred strategy for CRC prevention. Who should do the procedure? What new information do the latest studies offer? </itunes:summary>
      <itunes:keywords>colonoscopy, preventive medicine,preventative,recommendations,screening,screenings, colon screening,gastrointestinal,gi,routine,screenings, gastroenterology, </itunes:keywords>
      <itunes:duration>00:05:44</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson12-ColonoscopyControversies.mp4" length="37224448" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-vblog-Johnson12-ColonoscopyControversies.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>OTC Herbal and Nutritional Supplements and Kidney Disease</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns11-Herbs.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns11-Herbs.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Jeffrey S. Berns, MD, from the University of Pennsylvania School of Medicine, warns physicians to be aware of herbal and nutritional supplement use by patients. </description>
      <pubDate>Thu, 29 Jan 2009 03:27:00 GMT</pubDate>
      <itunes:subtitle>OTC Herbal and Nutritional Supplements and Kidney Disease</itunes:subtitle>
      <itunes:summary>In this video blog, Jeffrey S. Berns, MD, from the University of Pennsylvania School of Medicine, warns physicians to be aware of herbal and nutritional supplement use by patients. </itunes:summary>
      <itunes:keywords>renal disease,kidney disease,nephrosis,difficultly,disorder,disorders,dysfunction,nephropathy, alternative medicine,alternative,alternatives,complementary,medicine,non traditional medicine,treatment,tx, herbal treatment,medicine,medicines,tx, </itunes:keywords>
      <itunes:duration>00:02:49</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns11-Herbs.mp4" length="18874368" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-vblog-Berns11-Herbs.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Control of Noroviruses in Healthcare Facilities</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis06-Noroviruses.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis06-Noroviruses.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Lisa L. Maragakis, MD, MPH offers a brief review of noroviruses, their mode of transmission, diagnosis, and recommended control measures in healthcare facilities. </description>
      <pubDate>Thu, 29 Jan 2009 03:29:00 GMT</pubDate>
      <itunes:subtitle>Control of Noroviruses in Healthcare Facilities</itunes:subtitle>
      <itunes:summary>Lisa L. Maragakis, MD, MPH offers a brief review of noroviruses, their mode of transmission, diagnosis, and recommended control measures in healthcare facilities. </itunes:summary>
      <itunes:keywords>gastrointestinal infection,gi,infected, infection,infected, </itunes:keywords>
      <itunes:duration>00:03:50</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis06-Noroviruses.mp4" length="25794970" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-vblog-Maragakis06-Noroviruses.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Safe Storage for Perioperative Eye Medications</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-vblog-Brown1-PharmaceuticalRegulations.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-vblog-Brown1-PharmaceuticalRegulations.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Many practices have provided patients with perioperative medication storage kits that were provided by drug manufacturers, but the rules are changing. David M. Brown, MD, suggests alternatives. </description>
      <pubDate>Fri, 30 Jan 2009 03:33:00 GMT</pubDate>
      <itunes:subtitle>Safe Storage for Perioperative Eye Medications</itunes:subtitle>
      <itunes:summary>Many practices have provided patients with perioperative medication storage kits that were provided by drug manufacturers, but the rules are changing. David M. Brown, MD, suggests alternatives. </itunes:summary>
      <itunes:keywords>eye infection,infected,ocular,optic, patient compliance with treatment regimen,adherence,adherent,adhering,drug,issues,medication,patients,tx, surgery,surgical, ophthalmology, </itunes:keywords>
      <itunes:duration>00:02:16</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-vblog-Brown1-PharmaceuticalRegulations.mp4" length="14575206" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-vblog-Brown1-PharmaceuticalRegulations.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Loosening of Medicare Reimbursement for Off-Label Cancer Drugs</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall09-MedicareReimbursement.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall09-MedicareReimbursement.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. John Marshall urges oncologists to be responsible and consider patient benefit when prescribing costly medications, regardless of looser Medicare reimbursement rules. </description>
      <pubDate>Tue, 03 Feb 2009 03:34:00 GMT</pubDate>
      <itunes:subtitle>Loosening of Medicare Reimbursement for Off-Label Cancer Drugs</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. John Marshall urges oncologists to be responsible and consider patient benefit when prescribing costly medications, regardless of looser Medicare reimbursement rules. </itunes:summary>
      <itunes:keywords>neoplasm malignant,adenocarcinoma,adenocarcinomas,cancer,neoplasia,neoplasias,neoplasms, drug costs,medication, reimbursement nursing services,finance,payment, cost of illness,price, health care costs,expenditure,expenditures,health,healthcare, insurance </itunes:keywords>
      <itunes:duration>00:03:34</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall09-MedicareReimbursement.mp4" length="23802675" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall09-MedicareReimbursement.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Surgery Effectively Reduces Cancer Risks for Carriers of BRCA1, BRCA2 Mutations</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman22-Oopherectomy.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman22-Oopherectomy.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Prophylactic salpingo-oophorectomy sharply cuts cancer risks in women with BRCA1 or BRCA2 mutations, says Dr. Maurie Markman in this video blog report about a recently published meta-analysis. </description>
      <pubDate>Tue, 03 Feb 2009 03:37:00 GMT</pubDate>
      <itunes:subtitle>Surgery Effectively Reduces Cancer Risks for Carriers of BRCA1, BRCA2 Mutations</itunes:subtitle>
      <itunes:summary>Prophylactic salpingo-oophorectomy sharply cuts cancer risks in women with BRCA1 or BRCA2 mutations, says Dr. Maurie Markman in this video blog report about a recently published meta-analysis. </itunes:summary>
      <itunes:keywords>neoplasm malignant ovary,adenocarcinoma,adenocarcinomas,ca,cancer,carcinoma,carcinomas,malignancy,malignant neoplasm,neoplasms,ovarian,ovaries, neoplasm malignant breast,adenocarcinoma,adenocarcinomas,breasts,ca,cancer,carcinoma,carcinomas,female,malignan</itunes:keywords>
      <itunes:duration>00:02:43</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman22-Oopherectomy.mp4" length="18140365" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman22-Oopherectomy.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Blocking Endocannabinoids -- Outweighing the Benefits?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black30-WeightLossDrug.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black30-WeightLossDrug.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Dr. Henry Black discusses the future of rimonabant and endocannabinoid inhibitors. Will their effectiveness in curbing weight in high-risk individuals compensate for the depression linked with usage? </description>
      <pubDate>Tue, 03 Feb 2009 03:39:00 GMT</pubDate>
      <itunes:subtitle>Blocking Endocannabinoids -- Outweighing the Benefits?</itunes:subtitle>
      <itunes:summary>Dr. Henry Black discusses the future of rimonabant and endocannabinoid inhibitors. Will their effectiveness in curbing weight in high-risk individuals compensate for the depression linked with usage? </itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, hyperlipidemia,dyslipidemia,abnormalities,abnormality,disease,disorder,dyslipidemic,elevated,hyperlipemia,hyperlipidemias,hyperlipidemic, weight loss,losing,reduction,weigh,wt, depression,blue,blue</itunes:keywords>
      <itunes:duration>00:03:49</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black30-WeightLossDrug.mp4" length="25480397" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Cardio-Vblog-Black30-WeightLossDrug.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Levodopa and Unresponsive Symptoms in Parkinson's Disease</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-Vblog-Sethi1-Levodopa.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-Vblog-Sethi1-Levodopa.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Kapil D. Sethi, MD, discusses the limitations of levodopa therapy in controlling symptoms of Parkinson\'s disease.</description>
      <pubDate>Wed, 04 Feb 2009 03:44:00 GMT</pubDate>
      <itunes:subtitle>Levodopa and Unresponsive Symptoms in Parkinson's Disease</itunes:subtitle>
      <itunes:summary>In this video blog, Kapil D. Sethi, MD, discusses the limitations of levodopa therapy in controlling symptoms of Parkinson\'s disease.</itunes:summary>
      <itunes:keywords>Parkinson\'s disease,agitans,disorder,idiopathic,palsy,paralysis,parkinson,parkinsonism,shaking, </itunes:keywords>
      <itunes:duration>00:02:23</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-Vblog-Sethi1-Levodopa.mp4" length="15309210" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neuro-Vblog-Sethi1-Levodopa.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Survey Suggests That Cancer Patients May Be Willing to Participate in Clinical Trials</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman23-ClinicalTrials.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman23-ClinicalTrials.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. Maurie Markman observes that many cancer patients are willing to consider a clinical trial if the purpose and specifics of the study are explained clearly. </description>
      <pubDate>Thu, 05 Feb 2009 03:45:00 GMT</pubDate>
      <itunes:subtitle>Survey Suggests That Cancer Patients May Be Willing to Participate in Clinical Trials</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. Maurie Markman observes that many cancer patients are willing to consider a clinical trial if the purpose and specifics of the study are explained clearly. </itunes:summary>
      <itunes:keywords>neoplasm malignant,adenocarcinoma,adenocarcinomas,cancer,neoplasia,neoplasias,neoplasms, gynecological exam,annual,examination,female,gynecologic,gynecology,health,maintenance,normal,pap,paps,pe,pelvic,pelvis,physical,pulmonary embolus,routine,smear,woman</itunes:keywords>
      <itunes:duration>00:02:01</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman23-ClinicalTrials.mp4" length="13736346" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Markman23-ClinicalTrials.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Two Categories of Cancer Drugs?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall10-CancerDrugs.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall10-CancerDrugs.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. John Marshall muses about cancer drugs that provide a modest benefit for most patients vs those that provide enormous benefit for a few. Should we test them differently? </description>
      <pubDate>Fri, 06 Feb 2009 03:48:00 GMT</pubDate>
      <itunes:subtitle>Two Categories of Cancer Drugs?</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. John Marshall muses about cancer drugs that provide a modest benefit for most patients vs those that provide enormous benefit for a few. Should we test them differently? </itunes:summary>
      <itunes:keywords>neoplasm malignant,adenocarcinoma,adenocarcinomas,cancer,neoplasia,neoplasias,neoplasms, gastrointestinal disorder,conditions,digestive,disease,disorders,gi, neoplasm malignant stomach,adenocarcinoma,adenocarcinomas,ca,cancer,carcinoma,carcinomas,gastric,</itunes:keywords>
      <itunes:duration>00:04:9</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall10-CancerDrugs.mp4" length="28521267" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Onc-vblog-Marshall10-CancerDrugs.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Recent Breakthroughs in Pharmacogenomics</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Genomic-Vblog-Topol11-Pharmagenomics.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Genomic-Vblog-Topol11-Pharmagenomics.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Dr. Eric Topol discusses recent breakthroughs in pharmacogenomics involving cancer and cardiovascular drugs in his latest video blog. </description>
      <pubDate>Fri, 06 Feb 2009 03:49:00 GMT</pubDate>
      <itunes:subtitle>Recent Breakthroughs in Pharmacogenomics</itunes:subtitle>
      <itunes:summary>Dr. Eric Topol discusses recent breakthroughs in pharmacogenomics involving cancer and cardiovascular drugs in his latest video blog. </itunes:summary>
      <itunes:keywords>neoplasm malignant,adenocarcinoma,adenocarcinomas,cancer,neoplasia,neoplasias,neoplasms, cardiovascular disease,dis,disorder,disorders, genomics, pharmacogenomics, </itunes:keywords>
      <itunes:duration>00:04:49</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Genomic-Vblog-Topol11-Pharmagenomics.mp4" length="30828134" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Genomic-Vblog-Topol11-Pharmagenomics.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Plavix and PPIs -- Partners or Competitors in Promoting Good Outcomes?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-Vblog-Johnson13-PPI.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-Vblog-Johnson13-PPI.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>David A. Johnson, MD, FACG, FASGE, FACP talks about the controversies surrounding the use of clopidogrel (Plavix) and PPIs and suggests clinicians look closely at the data about benefits and risks. </description>
      <pubDate>Mon, 09 Feb 2009 03:52:00 GMT</pubDate>
      <itunes:subtitle>Plavix and PPIs -- Partners or Competitors in Promoting Good Outcomes?</itunes:subtitle>
      <itunes:summary>David A. Johnson, MD, FACG, FASGE, FACP talks about the controversies surrounding the use of clopidogrel (Plavix) and PPIs and suggests clinicians look closely at the data about benefits and risks. </itunes:summary>
      <itunes:keywords>myocardial infarction,heart attack,i,infarct,infarcted,infarction,infarctions,infarcts,maturation index,mi,miocardial,myocardial,recent, gastroenterology, </itunes:keywords>
      <itunes:duration>00:04:28</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-Vblog-Johnson13-PPI.mp4" length="30094131" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Gastro-Vblog-Johnson13-PPI.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Highlights of Macula 2009</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-Vblog-Brown2-Macula2009.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-Vblog-Brown2-Macula2009.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Experts met recently in New York at the Macula 2009 symposium to discuss macular disease and its treatment. David M. Brown, MD, highlights some of the most exciting advances presented at the meeting. </description>
      <pubDate>Mon, 09 Feb 2009 03:57:00 GMT</pubDate>
      <itunes:subtitle>Highlights of Macula 2009</itunes:subtitle>
      <itunes:summary>Experts met recently in New York at the Macula 2009 symposium to discuss macular disease and its treatment. David M. Brown, MD, highlights some of the most exciting advances presented at the meeting. </itunes:summary>
      <itunes:keywords>macula, retina, ophthalmology, </itunes:keywords>
      <itunes:duration>00:02:26</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-Vblog-Brown2-Macula2009.mp4" length="15623782" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-Vblog-Brown2-Macula2009.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Recent Articles on Pneumonia and Tracheobronchitis</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblog-Shorr10-PCCUpdate.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblog-Shorr10-PCCUpdate.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. Shorr discusses how definitions are changing relative to pneumonia and tracheobronchitis. Learn more about CAP, HCAP, HAP, VAP, and VAT. </description>
      <pubDate>Tue, 10 Feb 2009 04:03:00 GMT</pubDate>
      <itunes:subtitle>Recent Articles on Pneumonia and Tracheobronchitis</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. Shorr discusses how definitions are changing relative to pneumonia and tracheobronchitis. Learn more about CAP, HCAP, HAP, VAP, and VAT. </itunes:summary>
      <itunes:keywords>pneumonia,pneumonias, critical care,intensive, respiratory infection,infected,infections, ventilator-associated pneumonia,pneumonias, </itunes:keywords>
      <itunes:duration>00:05:35</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblog-Shorr10-PCCUpdate.mp4" length="34288435" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblog-Shorr10-PCCUpdate.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>IUDs: Trumping Myths With Evidence</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz09-IUDs.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz09-IUDs.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Why aren't more women in the United States using IUDs as a contraceptive method? In this video blog, Dr. Andrew Kaunitz clarifies the areas of confusion that have prevented wider use of IUDs. </description>
      <pubDate>Tue, 10 Feb 2009 04:05:00 GMT</pubDate>
      <itunes:subtitle>IUDs: Trumping Myths With Evidence</itunes:subtitle>
      <itunes:summary>Why aren't more women in the United States using IUDs as a contraceptive method? In this video blog, Dr. Andrew Kaunitz clarifies the areas of confusion that have prevented wider use of IUDs. </itunes:summary>
      <itunes:keywords>intrauterine device,IUD,insertion,placement, women's health, </itunes:keywords>
      <itunes:duration>00:04:45</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz09-IUDs.mp4" length="29989274" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-vblog-Kaunitz09-IUDs.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Early Steroid Discontinuation After Kidney Transplantation: Long-term Outcomes</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro15-Kidney-0.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro15-Kidney-0.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Ron Shapiro, MD, University of Pittsburgh, discusses kidney transplant half-lives after a regimen of rapid steroid withdrawal. </description>
      <pubDate>Tue, 10 Feb 2009 04:08:00 GMT</pubDate>
      <itunes:subtitle>Early Steroid Discontinuation After Kidney Transplantation: Long-term Outcomes</itunes:subtitle>
      <itunes:summary>In this video blog, Ron Shapiro, MD, University of Pittsburgh, discusses kidney transplant half-lives after a regimen of rapid steroid withdrawal. </itunes:summary>
      <itunes:keywords>kidney transplantation,allograft,renal,transplant,transplants, corticosteroid withdrawal, </itunes:keywords>
      <itunes:duration>00:02:06</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro15-Kidney-0.mp4" length="13212058" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro15-Kidney-0.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Good News for Those Considering Becoming Living Kidney Donors</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-Vblog-Berns12-Transplant.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-Vblog-Berns12-Transplant.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Jeffrey S. Berns, MD, from the University of Pennsylvania School of Medicine, discusses recent headline stories on kidney donation. </description>
      <pubDate>Tue, 10 Feb 2009 04:10:00 GMT</pubDate>
      <itunes:subtitle>Good News for Those Considering Becoming Living Kidney Donors</itunes:subtitle>
      <itunes:summary>In this video blog, Jeffrey S. Berns, MD, from the University of Pennsylvania School of Medicine, discusses recent headline stories on kidney donation. </itunes:summary>
      <itunes:keywords>kidney transplantation,allograft,renal,transplant,transplants, donor live, donor live related,alive,living, donor live unrelated,alive,living, </itunes:keywords>
      <itunes:duration>00:03:14</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-Vblog-Berns12-Transplant.mp4" length="21181235" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Neph-Vblog-Berns12-Transplant.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Central Venous Catheters Treated With Anti-infective Agents in Preventing Catheter-Related Bloodstream Infections</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblog-Shorr11-LitReview.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblog-Shorr11-LitReview.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. Shorr discusses a meta-analysis on the clinical effectiveness of CVCs treated with anti-infective agents in preventing catheter-related bloodstream infections. </description>
      <pubDate>Wed, 11 Feb 2009 03:31:00 GMT</pubDate>
      <itunes:subtitle>Central Venous Catheters Treated With Anti-infective Agents in Preventing Catheter-Related Bloodstream Infections</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. Shorr discusses a meta-analysis on the clinical effectiveness of CVCs treated with anti-infective agents in preventing catheter-related bloodstream infections. </itunes:summary>
      <itunes:keywords>critical care,intensive, critical care, </itunes:keywords>
      <itunes:duration>00:07:39</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblog-Shorr11-LitReview.mp4" length="49178214" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Pulm-vblog-Shorr11-LitReview.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Cryopreserved Agarose-Encapsulated Islets and the Future of Bioartificial Organs</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro14-Cry.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro14-Cry.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Ron Shapiro, MD, University of Pittsburgh, looks at a promising step in the development of bioartificial organs. </description>
      <pubDate>Wed, 11 Feb 2009 03:35:00 GMT</pubDate>
      <itunes:subtitle>Cryopreserved Agarose-Encapsulated Islets and the Future of Bioartificial Organs</itunes:subtitle>
      <itunes:summary>In this video blog, Ron Shapiro, MD, University of Pittsburgh, looks at a promising step in the development of bioartificial organs. </itunes:summary>
      <itunes:keywords>Shapiro on Transplantation - Cryopreserved Agarose-Encapsulated Islets and the Future of Bioartificial Organs</itunes:keywords>
      <itunes:duration>00:01:50</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro14-Cry.mp4" length="12373197" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro14-Cry.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Influenza Treatment: Now We Need a One-Two Punch</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-Vblog-Auwaerter11-Influenza-00.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-Vblog-Auwaerter11-Influenza-00.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>An unusual situation this flu season requires a change in drug treatment recommendations - learn about the latest guidelines in this video blog from Paul G. Auwaerter, MD </description>
      <pubDate>Tue, 17 Feb 2009 03:39:00 GMT</pubDate>
      <itunes:subtitle>Influenza Treatment: Now We Need a One-Two Punch</itunes:subtitle>
      <itunes:summary>An unusual situation this flu season requires a change in drug treatment recommendations - learn about the latest guidelines in this video blog from Paul G. Auwaerter, MD </itunes:summary>
      <itunes:keywords>influenza,grippe,flu, </itunes:keywords>
      <itunes:duration>00:03:28</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-Vblog-Auwaerter11-Influenza-00.mp4" length="21495808" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/ID-Vblog-Auwaerter11-Influenza-00.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Are Multifocal IOLs the Best Choice for Patients?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-Vblog-Brown3-MultifocalLenses-1.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-Vblog-Brown3-MultifocalLenses-1.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, David M. Brown, MD, discusses multifocal intraocular lenses and provides suggestions on how to determine which patients will benefit most.</description>
      <pubDate>Tue, 17 Feb 2009 03:43:00 GMT</pubDate>
      <itunes:subtitle>Are Multifocal IOLs the Best Choice for Patients?</itunes:subtitle>
      <itunes:summary>In this video blog, David M. Brown, MD, discusses multifocal intraocular lenses and provides suggestions on how to determine which patients will benefit most.</itunes:summary>
      <itunes:keywords>cataracts,cataract, cataract extraction,both eyes,cataracts,os,ou,removal,right eye, macula, ophthalmology, </itunes:keywords>
      <itunes:duration>00:02:08</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-Vblog-Brown3-MultifocalLenses-1.mp4" length="13946061" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-Vblog-Brown3-MultifocalLenses-1.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>My Top 10 Highlights -- CROI 2009</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HIV-Vblog-Sax02-CROI.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HIV-Vblog-Sax02-CROI.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>CROI 2009 just ended. Here are the take-home messages, reported in this video blog by Paul E. Sax, MD. </description>
      <pubDate>Thu, 19 Feb 2009 03:45:00 GMT</pubDate>
      <itunes:subtitle>My Top 10 Highlights -- CROI 2009</itunes:subtitle>
      <itunes:summary>CROI 2009 just ended. Here are the take-home messages, reported in this video blog by Paul E. Sax, MD. </itunes:summary>
      <itunes:keywords>antiretroviral therapy,antiretrovirals, arc,human immunodeficiency virus, </itunes:keywords>
      <itunes:duration>00:06:17</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HIV-Vblog-Sax02-CROI.mp4" length="41418752" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/HIV-Vblog-Sax02-CROI.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Factors Associated With Placebo Response in Juvenile Depression</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling9-JuvenileDepression-1.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling9-JuvenileDepression-1.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In his latest video blog, Dr. Robert Findling identifies the key factors linked to placebo response in children and adolescents taking antidepressants. </description>
      <pubDate>Fri, 20 Feb 2009 03:52:00 GMT</pubDate>
      <itunes:subtitle>Factors Associated With Placebo Response in Juvenile Depression</itunes:subtitle>
      <itunes:summary>In his latest video blog, Dr. Robert Findling identifies the key factors linked to placebo response in children and adolescents taking antidepressants. </itunes:summary>
      <itunes:keywords>depression,blue,blues,clinical,depressed,depressive,disease,disorder,melancholy,reaction, pediatrics, pharmacotherapy, </itunes:keywords>
      <itunes:duration>00:03:58</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling9-JuvenileDepression-1.mp4" length="25794970" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Psych-vblog-Findling9-JuvenileDepression-1.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Steroid-Free Regimens Associated With Good Medium-Term Outcomes in Renal Transplantation</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro16-SRTR-0.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro16-SRTR-0.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Ron Shapiro, MD, University of Pittsburgh, discusses a new study which suggests that we can continue to explore regimens that involve steroid avoidance after renal transplantation. </description>
      <pubDate>Tue, 24 Feb 2009 03:55:00 GMT</pubDate>
      <itunes:subtitle>Steroid-Free Regimens Associated With Good Medium-Term Outcomes in Renal Transplantation</itunes:subtitle>
      <itunes:summary>In this video blog, Ron Shapiro, MD, University of Pittsburgh, discusses a new study which suggests that we can continue to explore regimens that involve steroid avoidance after renal transplantation. </itunes:summary>
      <itunes:keywords>transplantation, steroids,steroid, </itunes:keywords>
      <itunes:duration>00:01:59</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro16-SRTR-0.mp4" length="12582912" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro16-SRTR-0.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Potential Agent for Treatment of Severe Antibody-Mediated Rejection</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro17-Antibody-0.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro17-Antibody-0.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Ron Shapiro, MD, University of Pittsburgh, discusses a case report in which a complement protein C5 antibody is used with PP/IVIg to salvage a kidney undergoing severe AMR. </description>
      <pubDate>Fri, 27 Feb 2009 03:57:00 GMT</pubDate>
      <itunes:subtitle>Potential Agent for Treatment of Severe Antibody-Mediated Rejection</itunes:subtitle>
      <itunes:summary>In this video blog, Ron Shapiro, MD, University of Pittsburgh, discusses a case report in which a complement protein C5 antibody is used with PP/IVIg to salvage a kidney undergoing severe AMR. </itunes:summary>
      <itunes:keywords>kidney transplantation,allograft,renal,transplant,transplants, transplant rejection acute,transplants, </itunes:keywords>
      <itunes:duration>00:02:24</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro17-Antibody-0.mp4" length="15099494" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Trans-Vblog-Shapiro17-Antibody-0.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>This Year&#39;s Awards for the Most Important Trials Go to... HYVET and ACCOMPLISH</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black35-Awards-1.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black35-Awards-1.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Dr. Henry Black describes why HYVET and ACCOMPLISH deserve high grades for their contribution to reducing hypertension. </description>
      <pubDate>Mon, 02 Mar 2009 04:01:00 GMT</pubDate>
      <itunes:subtitle>This Year&#39;s Awards for the Most Important Trials Go to... HYVET and ACCOMPLISH</itunes:subtitle>
      <itunes:summary>Dr. Henry Black describes why HYVET and ACCOMPLISH deserve high grades for their contribution to reducing hypertension. </itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, hypertension uncontrolled,control,controlled,healthy,high blood pressure,inadequate,poor,poorly,well, hypertension essential,essential hypertension,primary, </itunes:keywords>
      <itunes:duration>00:05:21</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black35-Awards-1.mp4" length="35337011" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black35-Awards-1.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Early Menopause and Cardiovascular Risk: What Is the Role of Estrogen Therapy?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Vblog-Kaunitz-Estrogen-2.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Vblog-Kaunitz-Estrogen-2.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, Dr. Andrew Kaunitz discusses the importance of estrogen replacement in young menopausal women. </description>
      <pubDate>Mon, 02 Mar 2009 04:02:00 GMT</pubDate>
      <itunes:subtitle>Early Menopause and Cardiovascular Risk: What Is the Role of Estrogen Therapy?</itunes:subtitle>
      <itunes:summary>In this video blog, Dr. Andrew Kaunitz discusses the importance of estrogen replacement in young menopausal women. </itunes:summary>
      <itunes:keywords>menopausal syndrome,climacteric state female,menopause,status,symptom,symptoms,syndromes,woman,women, postmenopausal on hormone replacement therapy,HRT,estrogen,hormones,menopausal,menopause,post,postmenopause,replacements,rx,syndrome,syndromes,treatment,</itunes:keywords>
      <itunes:duration>00:04:47</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Vblog-Kaunitz-Estrogen-2.mp4" length="32086426" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/WH-Vblog-Kaunitz-Estrogen-2.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>COURAGE and JUPITER--It&#39;s Time for Aggressive Measures in Preventing Cardiovascular Disease</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black35-JupiterCourage-1.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black35-JupiterCourage-1.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Dr. Henry Black describes why these important studies have demonstrated the value of an intensive prevention approach to cardiovascular disease. </description>
      <pubDate>Tue, 03 Mar 2009 04:04:00 GMT</pubDate>
      <itunes:subtitle>COURAGE and JUPITER--It&#39;s Time for Aggressive Measures in Preventing Cardiovascular Disease</itunes:subtitle>
      <itunes:summary>Dr. Henry Black describes why these important studies have demonstrated the value of an intensive prevention approach to cardiovascular disease. </itunes:summary>
      <itunes:keywords>atherosclerotic cardiovascular disease,arteriosclerosis,arteriosclerotic,ascvd,atherosclerotic coronary vessel disease,cardiovascular,disease,disorder, cardiovascular disease,dis,disorder,disorders, preventive care,preventative care,medicine,prevention, p</itunes:keywords>
      <itunes:duration>00:07:10</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black35-JupiterCourage-1.mp4" length="47081062" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black35-JupiterCourage-1.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>What Does It Take to Get a Generic Drug Approved? Surprisingly Little</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black37-Generics-1.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black37-Generics-1.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Dr. Henry Black describes the approval process for generics and his concerns about its effect on anti-hypertensive agents. </description>
      <pubDate>Thu, 05 Mar 2009 07:48:00 GMT</pubDate>
      <itunes:subtitle>What Does It Take to Get a Generic Drug Approved? Surprisingly Little</itunes:subtitle>
      <itunes:summary>Dr. Henry Black describes the approval process for generics and his concerns about its effect on anti-hypertensive agents. </itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, hypertension uncontrolled,control,controlled,healthy,high blood pressure,inadequate,poor,poorly,well, hypertension essential,essential hypertension,primary, drug costs,medication, drug therapy,medi</itunes:keywords>
      <itunes:duration>00:04:39</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black37-Generics-1.mp4" length="30723277" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black37-Generics-1.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Are Newer Retinal Treatments Superior to Usual Standard of Care?</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-Vblog-Brown04-RetinalTreatments-1.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-Vblog-Brown04-RetinalTreatments-1.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>In this video blog, David M. Brown, MD, stresses the importance of carefully evaluating newer retinal treatments, as they may not always be better than the current standard of care. </description>
      <pubDate>Mon, 09 Mar 2009 07:51:00 GMT</pubDate>
      <itunes:subtitle>Are Newer Retinal Treatments Superior to Usual Standard of Care?</itunes:subtitle>
      <itunes:summary>In this video blog, David M. Brown, MD, stresses the importance of carefully evaluating newer retinal treatments, as they may not always be better than the current standard of care. </itunes:summary>
      <itunes:keywords>diabetic retinopathy,retinopathy diabetic,diabetes mellitus,disease,disorder,dm,eye,ocular,optic, macular edema, retina, ophthalmology, </itunes:keywords>
      <itunes:duration>00:02:33</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-Vblog-Brown04-RetinalTreatments-1.mp4" length="17196646" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Ophth-Vblog-Brown04-RetinalTreatments-1.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>
    <item>
      <title>Do Men and Women Have Different Responses to Blood Pressure Treatments? Some Answers From the BPLTTC</title>
      <link>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black38-Trialist-1.mp4</link>
      <comments>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black38-Trialist-1.mp4</comments>
      <itunes:author>Medscape</itunes:author>
      <dc:creator>Medscape</dc:creator>
      <description>Dr. Henry Black discusses the effects of blood pressure drugs on population groups in light of the Blood Pressure Lowering Treatment Trialists Collaboration. </description>
      <pubDate>Mon, 09 Mar 2009 08:02:00 GMT</pubDate>
      <itunes:subtitle>Do Men and Women Have Different Responses to Blood Pressure Treatments? Some Answers From the BPLTTC</itunes:subtitle>
      <itunes:summary>Dr. Henry Black discusses the effects of blood pressure drugs on population groups in light of the Blood Pressure Lowering Treatment Trialists Collaboration. </itunes:summary>
      <itunes:keywords>hypertension,chronic,hbp,high blood pressure,hypertensin, healthy adult female,well woman,exam,normal,women,y,yo, hypertension essential,essential hypertension,primary, women&#39;s health, racism sexism ageism sexual orientation geographic pathology physical</itunes:keywords>
      <itunes:duration>00:04:04</itunes:duration>
      <enclosure url="http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black38-Trialist-1.mp4" length="27472691" type="video/mpeg" />
      <guid>http://www.podtrac.com/pts/redirect.mp4?http://images.medscape.com/pi/editorial/video/expertblogs/Card-Vblog-Black38-Trialist-1.mp4</guid>
      <itunes:explicit>no</itunes:explicit>
    </item>

  </channel>
</rss>
